WO2021015123A1 - Method for producing allergen-immobilized carrier, and method for detecting allergen-specific antibody - Google Patents

Method for producing allergen-immobilized carrier, and method for detecting allergen-specific antibody Download PDF

Info

Publication number
WO2021015123A1
WO2021015123A1 PCT/JP2020/027835 JP2020027835W WO2021015123A1 WO 2021015123 A1 WO2021015123 A1 WO 2021015123A1 JP 2020027835 W JP2020027835 W JP 2020027835W WO 2021015123 A1 WO2021015123 A1 WO 2021015123A1
Authority
WO
WIPO (PCT)
Prior art keywords
allergen
heat
carrier
allergen extract
extract
Prior art date
Application number
PCT/JP2020/027835
Other languages
French (fr)
Japanese (ja)
Inventor
和美 山下
正照 伊藤
大河 荒井
翔 若山
Original Assignee
東レ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 東レ株式会社 filed Critical 東レ株式会社
Priority to JP2020569213A priority Critical patent/JP7510620B2/en
Publication of WO2021015123A1 publication Critical patent/WO2021015123A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • C12M1/34Measuring or testing with condition measuring or sensing means, e.g. colony counters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals

Definitions

  • the present invention relates to a method for producing an allergen-immobilized carrier for detecting an allergen-specific antibody and a method for detecting an allergen-specific antibody using the allergen-immobilized carrier.
  • IgM When a foreign substance invades the body, various antibodies such as IgM, IgG, and IgA are produced, but it is the IgE antibody that is directly involved in the induction of allergies, and the IgE antibody that specifically binds to the allergen that causes allergies is specific. It is called an IgE antibody.
  • various chemical messengers such as histamine are released from mast cells, etc., and have actions such as vasodilation, bronchial smooth muscle contraction, and increased permeability of capillaries. Allergic symptoms such as redness, cough, and nasal discharge appear.
  • a dilute solution is prepared from extracts such as pollen, food, and mites, placed on the skin and pointed or scratched with a fine needle to the extent that it does not bleed (prick test, scratch test), or injected intradermally (prick test, scratch test). This is a method of observing wheals during an intradermal test).
  • the skin test has high sensitivity, it has a problem of low specificity, and there is a problem of negative / positive discrimination performance.
  • the intradermal test has a high possibility of shock and a high false positive rate, so it is a test to confirm the presence or absence of allergic symptoms by ingesting a small amount of food that is suspected to be allergic. A load test is performed.
  • this method there is still a risk of shock, so it is limited to implementation only in facilities where emergency response is sufficient.
  • the amount of histamine released from the basophils is measured by reacting the basophils in the collected blood with a dilute solution from extracts such as pollen, food and mites.
  • Histamine release test It is a minimally invasive test called blood sampling, and has the advantage of being able to reflect in vivo reactions, but about 20% of cases have Low-Responders that show low reactions, and these are not applicable to the histamine release test. turn into.
  • it is necessary to test the refrigerated blood within 3 days it is not widely used in clinical practice.
  • the allergy test that is generally performed in clinical practice is a method of measuring the amount of specific IgE antibody in blood.
  • an allergen-immobilized carrier in which the allergen is immobilized on the carrier is prepared, and a blood (serum / plasma) sample is reacted with the allergen-immobilized carrier to capture the specific IgE antibody that binds to the allergen. This is done by detecting a complex of an allergen and a specific antibody using an enzyme or a fluorescently labeled anti-IgE antibody.
  • a specific example of a specific IgE antibody test method widely used in clinical practice is the CAP (capsulated hydrophilic carrier polymer) method of Thermo Fisher Scientific Co., Ltd.
  • Non-Patent Document 1 describes a method in which a carrier in which an allergen is immobilized on a porous cellulose sponge is used in order to improve the sensitivity of the CAP method, and the amount of allergen immobilized per carrier is increased by increasing the surface area. Has been done.
  • Patent Document 1 describes a chip for allergy diagnosis in which allergens are extracted from a heated food (garlic) and an unheated food, and these extracted allergens are individually spotted.
  • the present invention meets such needs, and provides a method for producing an allergen-immobilized carrier for an allergy test capable of detecting an allergen-specific antibody with high sensitivity, and a method for detecting an allergen-specific antibody using the carrier. To do.
  • the present inventors heat-treated the allergen extract extracted from the allergen raw material in the production of the allergen-immobilized carrier for allergy test, and heat-treated the allergen extract. It was found that by immobilizing the substance on the carrier, the amount of allergen immobilized is increased as compared with the carrier on which the allergen extract not subjected to the heat treatment is immobilized. Further, they have found that a specific antibody can be detected with higher sensitivity than before by using an allergen-immobilized carrier prepared by this method, and completed the present invention.
  • the present invention provides the following.
  • a method for producing an allergen-immobilized carrier for detecting an allergen-specific antibody A step of heating the allergen extract to obtain a heat-treated product of the allergen extract [1], and a step of immobilizing the heat-treated product obtained in the above step [1] on a carrier [2].
  • a method for producing a carrier including. (2) The production method according to (1), wherein the heating temperature in the step [1] is 60 ° C. or higher and lower than 100 ° C. (3) The production method according to (1) or (2), wherein the specific antibody is a specific IgE antibody. (4) The method according to any one of (1) to (3), wherein in the step [2], the heat-treated product is immobilized on the carrier by a covalent bond.
  • a sample is brought into contact with an allergen-immobilized carrier produced by any of the methods (1) to (4), and a specific antibody in the sample forming a complex with the allergen immobilized on the carrier is obtained.
  • a method for detecting an allergen-specific antibody in a sample which comprises a step of detecting.
  • an allergen-immobilized carrier for allergy testing, by immobilizing the allergen extract after heat treatment, it is possible to obtain an allergen-immobilized carrier in which more allergens are immobilized than when used without heating. Become. Further, by using the carrier, it becomes possible to detect an allergen-specific antibody with high sensitivity even with a small amount of sample.
  • the allergen extract used in the present invention is an extract of a protein contained in an allergic raw material.
  • Allergy raw materials are a general term for materials containing allergens that cause allergies, and specific examples thereof include microorganisms, plants, animals, insects and house dust, and foods containing these. Whether or not it causes allergies depends on the constitution.
  • microorganisms containing allergens include Alternaria, Aspergillus, Candida, Malassezia, and mites.
  • Examples of plants containing allergens include sugi, hinoki, alder, birch, Dactylis, ragweed, mugwort and timothy, and pollen of these.
  • Examples of animals containing allergens include cats, dogs, mice, rats, hamsters, rabbits, inco, ducks and the like.
  • Examples of insects containing allergens include moths, cockroaches and bees.
  • Examples of foods containing allergens include eggs, milk, wheat, peanuts, soybeans, soba, sesame, rice, shrimp, crab, squid, octopus, kiwi, banana, apple, peach, tomato, garlic, tuna, salmon, mackerel. , Beef, pork, chicken and so on.
  • allergen extract a commercially available one may be used, or one extracted from allergen raw materials by oneself may be used.
  • Commercially available allergen extracts can be purchased from ITEA Inc., Cosmo Bio Co., Ltd., and the like.
  • the method for extracting the allergen extract is not particularly limited, but it may be extracted by a known method. Specifically, it can be extracted by the following method.
  • the allergen raw material is finely chopped or crushed after freeze-drying, homogenized by adding a solvent, extracted overnight at 4 ° C., and then centrifuged to obtain a supernatant. Subsequently, the supernatant is filtered with a filter paper, gauze, a filter or the like several times, and then centrifuged to obtain a supernatant. Further, the supernatant obtained by dialyzing the supernatant with a buffer solution or further freeze-drying can be used as the allergen extract of the present invention.
  • the solvents used for extraction include ion-exchanged water, phosphate buffered saline (PBS), sodium phosphate buffer, sodium hydrogen carbonate aqueous solution, Tris buffer, acetate buffer, and citrate buffer.
  • a carbonate buffer, Good's buffer, or other solution suitable for dissolving proteins may be used.
  • sodium phosphate buffer solution and sodium hydrogen carbonate aqueous solution are preferably used as solvents.
  • saccharides such as Dimethyl sulfoxide (DMSO), N, N-dimethylformamide (DMF), alcohols such as glycerol, methanol or ethanol, glucose, fructose and trehalose are added at the time of extraction. You may.
  • the allergen extract used in the present invention may be a crude extract or a purified product obtained by purifying the crude extract.
  • An example of a method for purifying a crude extract is, for example, in the case of an allergic raw material containing a large amount of lipid, a method of removing lipid by freeze-drying, pulverizing, treating with hexane, obtaining pellets and drying. Examples thereof include a method of removing impurities by ion exchange chromatography, gel chromatography, ultrafiltration and the like, and isolation of a specific protein.
  • the present invention is characterized in that the allergen extract is heat-treated and then immobilized on a carrier.
  • the heat treatment temperature of the allergen extract is preferably 60 ° C. or higher and lower than 100 ° C., more preferably 80 ° C. or higher and lower than 100 ° C., and most preferably 80 ° C. or higher and 95 ° C. or lower.
  • the heating time can be appropriately set according to the amount of the allergen extract to be treated, but is preferably 1 minute or more. There is no particular upper limit to the heating time, and the heating time is, for example, 60 minutes or less, particularly 30 minutes or less, but usually 10 minutes is sufficient.
  • the heat treatment of the allergen extract is preferably performed by dissolving the allergen extract in a liquid.
  • the solvent used in the above allergen extraction can be used.
  • the liquid for dissolving the allergen extract is phosphate buffered saline (PBS), ion-exchanged water, or sodium phosphate.
  • PBS phosphate buffered saline
  • a solvent suitable for dissolving a buffer solution, an aqueous sodium hydrogen carbonate solution, a Tris buffer solution, an acetate buffer solution, a citrate buffer solution, a carbonate buffer solution, Good's buffer, and other proteins can be used.
  • the heat treatment of the allergen extract may be carried out in the presence of a surfactant.
  • Surfactants are preferably used because they have a protein solubilizing effect and a coagulation preventing effect during heat treatment.
  • the presence of the surfactant improves the wettability and enables uniform immobilization.
  • the effect of improving wettability and enabling uniform immobilization can be obtained even when a surfactant is added after the heat treatment, so that the heat treatment is performed in the absence of the surfactant. Even in this case, it is also preferable to add a surfactant after the heat treatment.
  • surfactants such as anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants, all of which can be preferably used.
  • anionic surfactant include sodium dodecyl sulfate (SDS) and the like.
  • amphoteric tenside agents include 3-[(3-Cholamidopropyl) dimethyramminio] propanesulfonate (CHAPS) and 3-[(3-Cholamidoplopyl) dimethyramminio) -2-hydropypropanesulfone.
  • Nonionic surfactants include Triton X-100 (trademark), Triton X-114 (trademark), NP-40, Brij-35, Brij-58, Tween20 (trademark), Tween80 (trademark), Octyl Glucside, Octyl thioglucoside, etc. Can be mentioned.
  • SDS and Tween 20 TM are particularly preferably used. If the concentration of the surfactant is too high, the heat-treated allergen extract may be denatured to the extent that it cannot bind to the specific IgE antibody. Therefore, when SDS or Tween 20 (trademark) is used, it is preferable to add the allergen extract to the solution to be heat-treated so that the final concentration is 0.001 to 0.1% by volume. It is preferable to add the mixture in an amount of 0.003 to 0.05% by volume.
  • the allergen-immobilized carrier produced by the method of the present invention is contained in the sample, which forms a complex with the allergen on the surface of the carrier by contacting the sample with the carrier on which the heat-treated product of the allergen extract is immobilized. It is possible to detect a specific antibody such as a specific IgE antibody. That is, by using the allergen-immobilized carrier provided by the present invention, it is possible to detect a specific antibody that forms a complex with the allergen in the sample.
  • heat-treated products of a plurality of allergen extracts are immobilized on a plurality of locations on one carrier, and each heat-treated product can be contacted with a sample in one reaction field (described later), a smaller amount is required. It is more preferable because a plurality of allergen-specific IgE antibodies can be simultaneously tested from the sample.
  • Examples of the carrier material for immobilizing the heat-treated product of the allergen extract include glass, resin, metal, metal oxide, gel, cellulose, carbon material, etc., but any carrier capable of immobilization can be used. Not limited.
  • As the resin used as the material of the carrier polystyrene, polycarbonate, polyethylene, polypropylene, polymethylmethacrylate, polyethylene terephthalate, polyether sulfone, polybutylene terephthalate, polybutylene succinate, polylactic acid, polyamide resin, ABS and the like are used. be able to.
  • As the metal used as the material of the carrier gold, silver, copper, platinum, titanium, palladium, iron, aluminum, nickel, alloys thereof and the like can be used.
  • As the metal oxide used as the material of the solid phase carrier silicon dioxide, aluminum oxide, cerium oxide, zirconium oxide, composite oxide and the like can be used.
  • the shape of the carrier may be appropriately selected from plate-like, thin film, particle-like, porous, etc., but is preferably plate-like.
  • a resin material such as polymethylmethacrylate, polystyrene, or polypropylene, which can be produced by injection molding, is preferable from the viewpoint of productivity.
  • a method of immobilizing the heat-treated product of the allergen extract on the carrier there are physical adsorption and chemical bond, but the method of chemically immobilizing is preferable. Further, among the chemical immobilizations, a bond by a covalent bond is preferable.
  • a carrier having a functional group capable of binding to the heat-treated product of the allergen extract is used. For example, by generating a carboxyl group on the carrier by a known method, it can be covalently immobilized with the amino group of the heat-treated product of the allergen extract.
  • the carrier is an acrylic resin such as polymethylmethacrylate, the following methods can be mentioned.
  • the surface of the carrier is hydrolyzed with an alkaline aqueous solution such as caustic soda to generate a carboxyl group on the resin surface, and then the carboxyl group and the amino group contained in the heat-treated product of the allergen extract are directly covalently bonded (amide). It can be fixed by binding).
  • a maleimide group is introduced into the carboxyl group generated on the carrier by an ester bond, and the maleimide group is covalently bonded to the thiol group derived from the cysteine residue contained in the heat-treated product of the allergen extract. It can also be fixed by.
  • the method itself for covalently bonding a protein to a carboxyl group on a carrier is well known, and is specifically described in the following examples.
  • the heat-treated product of the allergen extract when the heat-treated product of the allergen extract is chemically immobilized by a covalent bond, the heat-treated product of the allergen extract can be dissolved in a solvent.
  • the solvent include phosphate buffered saline (PBS), ion-exchanged water, sodium phosphate buffer, sodium hydrogen carbonate aqueous solution, Tris buffer, acetate buffer, citrate buffer, carbonate buffer, Good.
  • PBS phosphate buffered saline
  • a solvent suitable for dissolving's buffer and other proteins can be used. If the same solvent can be used consistently from dissolving, heating, and immobilizing the allergen extract to the carrier, no solvent replacement operation is required on the way, and the immobilization carrier of the heat-treated product of the allergen extract is not required. It is preferable because a simple process can be adopted for producing the above.
  • PBS, sodium phosphate buffer solution, and sodium hydrogen carbonate aqueous solution are preferably used.
  • a method of bringing the solution of the heat-treated product of the allergen extract into contact with the carrier a method of immersing the carrier in the solution or a method of dropping the solution onto the carrier can be used. If the allergen and the sample are immobilized so that they can come into contact with each other at the same time in one reaction field, multiple allergies can be detected from a smaller number of samples at the same time. Therefore, on the same plate-like carrier using a known spotting device. It is preferable to spot and immobilize the solutions of the heat-treated products of the plurality of allergen extracts.
  • contacting the allergen and the sample in one reaction field means that the sample is added and brought into contact with a carrier in which heat-treated products of a plurality of allergen extracts are independently immobilized without partition walls.
  • the specific antibody in the sample can be freely contacted in the same space as the heat-treated product of any of the immobilized allergen extracts.
  • the amount of immobilized allergen can be determined by a method of directly quantifying the amount of protein of the allergen on the surface of the carrier, or by reacting the immobilized allergen with a solution containing an acid or a reducing agent to dissociate the allergen from the carrier. Any method of quantifying the amount of protein present in the protein by the BCA method, the Bradford method, the ultraviolet absorption altitude method, or the like can be used. Of these, since it is not easy to disperse an allergen covalently bonded to the carrier, for example, an amide bond from the carrier, a method of directly quantifying the amount of allergen protein on the surface of the carrier is preferable.
  • Examples of the method for quantifying the protein amount of the allergen on the surface of the carrier include observation with a high-speed atomic force microscope and surface plasmon resonance method.
  • the carrier is made of resin, time-of-flight secondary ion mass spectrometry is used.
  • the quantitative method used is preferable.
  • the sample used in the present invention is preferably derived from a body fluid.
  • Body fluids include blood, sweat, urine, tears, saliva, sputum / airway secretions, breast milk, amniotic fluid, cerebrospinal fluid, ascites, pleural fluid, joint fluid, semen, vaginal discharge, etc., but specific IgE antibodies. Blood containing a large amount of specific antibodies such as the above is preferable. Further, the sample may be pretreated if necessary. For example, in the case of blood, serum or plasma can also be preferably used.
  • the complex of the allergen on the surface of the carrier and the specific antibody can be detected by the following method.
  • a detection method using a surface plasmon resonance method based on a difference in refractive index due to coupling or a quartz crystal microbalance method using a difference in resonance frequency as a detection principle can be mentioned.
  • a method using a secondary antibody such as a fluorescent substance (fluorescent dye), an enzyme that produces a color-developing / luminescent substance, and an anti-IgE antibody modified (labeled) with a radioisotope element or the like can also be mentioned.
  • a method using an anti-IgE antibody modified with a fluorescent substance which is safe and easy to handle, is preferable.
  • Quantitative immunoassays in specific allergy diagnosis usually use or refer to the World Health Organization IgE International Standard (WHO International Standard immunoglobulin (IgE), human serum) to construct a calibration system.
  • WHO International Standard immunoglobulin (IgE) This international standard product is a freeze-dried sample of total IgE antibody derived from human serum (The 3rd International Standard for serum IgE: report of the international collaborative group 21 BS / 2013.2220), for example, can be used to prepare total IgE antibody standard solutions of various concentrations and quantified by comparing the measured values of the standard and the sample.
  • the crab allergen extract was purchased from Torii Pharmaceutical Co., Ltd.
  • the cockroach allergen extract was purchased from Biosuta.
  • the alder pollen allergen extract was purchased from ITEA.
  • the ragweed allergen extract was purchased from Torii Pharmaceutical Co., Ltd.
  • the tomato allergen extract was purchased from Torii Pharmaceutical Co., Ltd.
  • the birch pollen allergen extract was purchased from ITEA.
  • the cypress pollen allergen extract was purchased from ITEA.
  • the banana allergen extract was prepared by the method of Reference Example 1 using banana as an allergic raw material.
  • the heated garlic allergen extract was prepared by heating raw garlic at 95 ° C. for 20 minutes as an allergen raw material by the method of Reference Example 1.
  • the soybean allergen extract was purchased from Stallergenes Greer.
  • Reference Example 1 Preparation of allergen extract
  • the allergen raw material was finely ground, 3 times the weight of PBS was added and stirred, and the mixture was extracted overnight at 4 ° C. and then centrifuged to obtain a supernatant. Subsequently, the supernatant was filtered through a filter paper, and the supernatant obtained by centrifugation was dialyzed against PBS to obtain an allergen extract.
  • a polymethylmethacrylate (PMMA) resin substrate (manufactured by Kuraray, outer diameter 75 mm ⁇ 25 mm ⁇ 1 mm, average molecular weight 30,000) was used as a carrier.
  • the substrate was immersed in 10 specified sodium hydroxide at 70 ° C. for 14 hours, washed with pure water three times, and dried. In this way, the side chain of PMMA on the surface of the substrate was hydrolyzed to generate a carboxyl group.
  • the allergen-immobilized carrier for detecting specific antibodies prepared in Reference Example 2 was immersed in a PBS solution containing 1 wt% bovine serum albumin (BSA) (manufactured by Sigma-Aldrich) at 4 ° C. overnight for blocking treatment. , Washed 3 times with PBST.
  • BSA bovine serum albumin
  • a solution diluted 3-fold with a PBS aqueous solution containing 1 wt% BSA for 10 ⁇ L of each sample was added dropwise to the portion of the carrier on which the allergen was immobilized, and a gap cover glass (manufactured by Matsunami Glass Industry Co., Ltd .: 24 mm) was added dropwise. It was sealed with a cover ( ⁇ 25 mm, gap size 20 ⁇ m). After reacting at 37 ° C. for 2 hours, the gap cover glass was removed and washed 3 times with PBST.
  • a gap cover glass manufactured by Matsunami Glass Industry Co., Ltd .: 24 mm
  • a 30 ⁇ L substrate was added with a Dilight-650 dye-labeled anti-human IgE goat polyclonal antibody (manufactured by Novus biologicals) diluted 1000-fold with PBST containing 1 wt% BSA, covered with a gap cover glass, and reacted at room temperature for 1 hour. It was. Then, the gap cover glass was removed, washed with PBST three times, dried, and the fluorescence intensity was measured with a scanner device (3D-GeneScanner 3000 manufactured by Toray Industries, Inc.) under the following conditions.
  • a scanner device (3D-GeneScanner 3000 manufactured by Toray Industries, Inc.
  • Fluorescence intensity measurement condition Device 3D-GeneScanner3000 (manufactured by Toray Industries, Inc.) Excitation light wavelength: 635 nm Detection wavelength: 670 nm PMT: 30.
  • Example 1 Preparation of immobilized carrier of heat-treated product of canial allergen extract, measurement of allergen-specific antibody
  • the canial allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0) so as to have a final concentration of 1 mg / mL. It was dissolved and the solution was prepared to 100 ⁇ L. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 TM was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
  • an allergen-immobilized carrier for detecting a specific antibody of a crab allergen was prepared by the method described in Reference Example 2.
  • the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
  • crab allergy-positive plasma was purchased from PlasmaLab and used.
  • plasma confirmed to be negative as a result of a crab allergy test by SRL, Inc. was used.
  • Table 1 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
  • Comparative Example 1 Preparation of an immobilized carrier of a non-heat-treated product of a crab allergen extract and measurement of an allergen-specific antibody The same method as in Example 1 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 1.
  • Example 2 Preparation of immobilized carrier of heat-treated product of canial allergen extract, measurement of allergen-specific antibody SDS as a surfactant during heat treatment of allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0). The procedure was the same as in Example 1 except that the mixture was added so as to have a final concentration of 0.02% by volume. The measurement results are shown in Table 1.
  • Comparative Example 2 Preparation of immobilized carrier of non-heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 2 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 1.
  • Example 3 Preparation of immobilized carrier of heat-treated product of gokibrial allergen extract, measurement of allergen-specific antibody
  • the gokibrial allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0) to a final concentration of 1 mg / mL. It was dissolved and the solution was prepared to 100 ⁇ L. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 TM was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
  • an allergen-immobilized carrier for detecting a specific antibody of a cockroach allergen was prepared by the method described in Reference Example 2.
  • the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
  • cockroach allergy positive plasma was purchased from PlasmaLab and used.
  • plasma confirmed to be negative as a result of a cockroach allergy test by SRL, Inc. was used.
  • Table 2 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
  • Example 4 Preparation of immobilized carrier of heat-treated product of cockroach allergen extract, measurement of allergen-specific antibody The same method as in Example 3 was carried out except that the heat treatment condition of the allergen extract was set to 60 ° C. .. The measurement results are shown in Table 2.
  • Comparative Example 3 Preparation of a non-heated immobilized carrier of cockroach allergen extract and measurement of allergen-specific antibody The same method as in Example 3 was carried out except that the allergen extract was not heat-treated. .. The measurement results are shown in Table 2.
  • Example 5 Preparation of immobilized carrier of heat-treated product of gokibrial allergen extract, measurement of allergen-specific antibody SDS as a surfactant during heat treatment of allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0). The procedure was the same as in Example 3 except that the mixture was added so as to have a final concentration of 0.02% by volume. The measurement results are shown in Table 2.
  • Example 6 Preparation of immobilized carrier of heat-treated product of cockroach allergen extract, measurement of allergen-specific antibody The same method as in Example 5 was carried out except that the heat treatment condition of the allergen extract was set to 60 ° C. .. The measurement results are shown in Table 2.
  • Comparative Example 4 Preparation of a non-heated immobilized carrier of cockroach allergen extract and measurement of allergen-specific antibody The same method as in Example 5 was carried out except that the allergen extract was not heat-treated. .. The measurement results are shown in Table 2.
  • Example 7 Preparation of immobilized carrier of heat-treated product of Hannoki pollen allergen extract, measurement of allergen-specific antibody 20 mM sodium phosphate buffer (pH 7.0) so that the final concentration of Hannoki pollen allergen extract is 1 mg / mL. ) To prepare the solution to 100 ⁇ L. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 TM was added to a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
  • an allergen-immobilized carrier for detecting a specific antibody of alder pollen allergen was prepared by the method described in Reference Example 2.
  • the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
  • alder pollen allergy-positive plasma was purchased from PlasmaLab and used.
  • a negative sample plasma confirmed to be negative as a result of the alder pollen allergy test of SRL, Inc. was used.
  • Table 3 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
  • Example 8 Preparation of immobilized carrier of heat-treated product of alder pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 7 was carried out except that the heat treatment condition of the allergen extract was set to 60 ° C. did. The measurement results are shown in Table 3.
  • Comparative Example 5 Preparation of a non-heated immobilized carrier of alder pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 7 was carried out except that the allergen extract was not heat-treated. did. The measurement results are shown in Table 3.
  • Example 9 Preparation of immobilized carrier of heat-treated product of Hannoki pollen allergen extract, measurement of allergen-specific antibody SDS was used as a surfactant during heat treatment of allergen extract, and 20 mM sodium phosphate buffer (pH 7.0). It was carried out in the same manner as in Example 7 except that it was added and used so as to have a final concentration of 0.02% by volume. The measurement results are shown in Table 3.
  • Example 10 Preparation of immobilized carrier of heat-treated product of alder pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 9 was carried out except that the heat treatment condition of the allergen extract was set to 60 ° C. did. The measurement results are shown in Table 3.
  • Example 11 Preparation of immobilized carrier of heat-treated product of ragweed pollen allergen extract, measurement of allergen-specific antibody 20 mM sodium phosphate buffer (pH 7.0) so that the final concentration of ragweed pollen allergen extract is 1 mg / mL. ) To prepare the solution to 100 ⁇ L. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 TM was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
  • an allergen-immobilized carrier for detecting a specific antibody of ragweed pollen allergen was prepared by the method described in Reference Example 2.
  • the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
  • ragweed pollen allergy-positive plasma was purchased from Abbaltis and used.
  • a negative sample plasma confirmed to be negative as a result of the ragweed pollen allergy test of SRL, Inc. was used.
  • Table 4 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
  • Comparative Example 7 Preparation of immobilized carrier of non-heat-treated product of ragweed pollen allergen extract, measurement of allergen-specific antibody Performed in the same manner as in Example 11 except that the heat treatment of the allergen extract was not performed. did. The measurement results are shown in Table 4.
  • Example 12 Preparation of immobilized carrier of heat-treated product of ragweed pollen allergen extract, measurement of allergen-specific antibody SDS was used as a surfactant during heat treatment of allergen extract, and 20 mM sodium phosphate buffer (pH 7.0). It was carried out in the same manner as in Example 11 except that it was added and used so as to have a final concentration of 0.02% by volume. The measurement results are shown in Table 4.
  • Comparative Example 8 Preparation of immobilized carrier of non-heat-treated product of ragweed pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 12 was carried out except that the heat treatment of the allergen extract was not carried out. did. The measurement results are shown in Table 4.
  • Example 13 Preparation of immobilized carrier of heat-treated product of tomato allergen extract, measurement of allergen-specific antibody Put the tomato allergen extract in 20 mM sodium phosphate buffer (pH 7.0) so as to have a final concentration of 1 mg / mL. It was dissolved and the solution was prepared to 100 ⁇ L. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 TM was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
  • 20 mM sodium phosphate buffer pH 7.0
  • an allergen-immobilized carrier for detecting a specific antibody of tomato allergen was prepared by the method described in Reference Example 2.
  • the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
  • tomato allergy-positive plasma was purchased from PlasmaLab and used.
  • plasma confirmed to be negative as a result of a tomato allergy test by SRL, Inc. was used.
  • Table 5 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
  • Comparative Example 9 Preparation of immobilized carrier of non-heat-treated tomato allergen extract, measurement of allergen-specific antibody The same method as in Example 13 was carried out except that the allergen extract was not heat-treated. ..
  • Example 14 Preparation of immobilized carrier of heat-treated product of tomato allergen extract, measurement of allergen-specific antibody SDS was added as a surfactant during heat treatment of allergen extract. The procedure was the same as in Example 13 except that SDS was added to a 20 mM sodium phosphate buffer solution (pH 7.0) so as to have a final concentration of 0.02% by volume.
  • Comparative Example 10 Preparation of an immobilized carrier of a non-heat-treated tomato allergen extract and measurement of allergen-specific antibody The same method as in Example 14 was carried out except that the allergen extract was not heat-treated. ..
  • Example 15 Preparation of immobilized carrier of heat-treated product of Shirakamba pollen allergen extract, measurement of allergen-specific antibody 20 mM phosphorus containing 0.02% by volume SDS of Shirakamba pollen allergen extract to a final concentration of 1 mg / mL. It was dissolved in sodium acid buffer (pH 7.0) to prepare 100 ⁇ L of the solution. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 TM was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
  • an allergen-immobilized carrier for detecting a specific antibody of the birch pollen allergen was prepared by the method described in Reference Example 2.
  • the fluorescence intensity of the positive sample and the negative sample was measured by the method described in Reference Example 3, and the allergen-specific antibody was detected.
  • birch pollen allergy-positive plasma was purchased from PlasmaLab and used.
  • plasma confirmed to be negative as a result of the birch pollen allergy test of SRL, Inc. was used.
  • Table 6 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
  • Example 16 Preparation of immobilized carrier of heat-treated product of birch pollen pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 15 was carried out except that the heat treatment condition of the allergen extract was set to 60 ° C. did. The measurement results are shown in Table 6.
  • Comparative Example 11 Preparation of immobilized carrier of non-heat-treated birch pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 15 was carried out except that the allergen extract was not heat-treated. did. The measurement results are shown in Table 6.
  • Example 17 Preparation of immobilized carrier of heat-treated product of hinoki pollen allergen extract, measurement of allergen-specific antibody 20 mM sodium phosphate buffer (pH 7.0) so that the final concentration of hinoki pollen allergen extract is 1 mg / mL. ) To prepare the solution to 100 ⁇ L. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 TM was added to a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
  • an allergen-immobilized carrier for detecting a specific antibody of hinoki pollen allergen was prepared by the method described in Reference Example 2.
  • the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
  • hinoki pollen allergy-positive plasma was purchased from Abbaltis and used.
  • a negative sample plasma confirmed to be negative as a result of the hinoki pollen allergy test of SRL, Inc. was used.
  • Table 7 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
  • Example 18 Preparation of immobilized carrier of heat-treated product of hinoki pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 17 was carried out except that the heat treatment condition of the allergen extract was set to 60 ° C. did. The measurement results are shown in Table 7.
  • Comparative Example 12 Preparation of immobilized carrier of non-heat-treated hinoki pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 17 was carried out except that the heat treatment of the allergen extract was not carried out. did. The measurement results are shown in Table 7.
  • Example 19 Preparation of immobilized carrier of heat-treated product of banana allergen extract, measurement of allergen-specific antibody
  • the banana allergen extract was diluted with PBS to a final concentration of 1 mg / mL, and the solution was prepared to 100 ⁇ L. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 TM was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
  • an allergen-immobilized carrier for detecting a specific antibody of a banana allergen was prepared by the method described in Reference Example 2.
  • banana allergy-positive plasma was purchased from PlasmaLab and used.
  • plasma confirmed to be negative as a result of a banana allergy test by SRL, Inc. was used.
  • Table 8 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
  • Comparative Example 13 Preparation of immobilized carrier of non-heat-treated banana allergen extract, measurement of allergen-specific antibody The same method as in Example 19 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 8.
  • Example 20 Preparation of immobilized carrier of heat-treated banana allergen extract, measurement of allergen-specific antibody SDS was added to 20 mM sodium phosphate buffer (pH 7.0) as a surfactant during heat treatment of allergen extract. The procedure was the same as in Example 19 except that the mixture was added so as to have a final concentration of 0.02% by volume. The measurement results are shown in Table 8.
  • Comparative Example 14 Preparation of an immobilized carrier of a non-heat-treated banana allergen extract and measurement of allergen-specific antibody The same method as in Example 20 was carried out except that the allergen extract was not heat-treated. .. The measurement results are shown in Table 8.
  • Example 21 Preparation of immobilized carrier of heat-treated product of canial allergen extract, measurement of allergen-specific antibody
  • the canial allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0) so as to have a final concentration of 1 mg / mL. It was dissolved and the solution was prepared to 100 ⁇ L. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 TM was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
  • an allergen-immobilized carrier for detecting a specific antibody of a crab allergen was prepared by the method described in Reference Example 2.
  • the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
  • allergy class 4 crab allergy positive plasma and allergy class 5 crab allergy positive plasma were obtained from PlasmaLab and used.
  • Example 22 Preparation of immobilized carrier of heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 21 was carried out except that the heat treatment condition of the allergen extract was set to 90 ° C. .. The measurement results are shown in Table 9.
  • Example 23 Preparation of immobilized carrier of heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 21 was carried out except that the heat treatment conditions of the allergen extract were set to 80 ° C. .. The measurement results are shown in Table 9.
  • Comparative Example 15 Preparation of immobilized carrier of non-heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 21 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 9.
  • the value of the fluorescence intensity ratio (positive sample (class 5) / positive sample (class 4)) of the allergy class 5 positive sample to the allergy class 4 positive sample is also the value when the heat-treated allergen extract is used. It was shown to be larger than when the non-heat-treated product was used. That is, it was shown that the allergen class can be discriminated with high accuracy and the concentration of the specific IgE antibody can be measured by using the allergen extract after heat treatment.
  • Example 24 Preparation of immobilized carrier of heat-treated product of canial allergen extract, measurement of allergen-specific antibody SDS was added as a surfactant during heat treatment of allergen extract to a final concentration of 20 mM sodium phosphate buffer pH 7.0. It was carried out in the same manner as in Example 21 except that it was added and used so as to be 0.02% by volume. The measurement results are shown in Table 10.
  • Example 25 Preparation of immobilized carrier of heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 24 was carried out except that the heat treatment conditions of the allergen extract were set to 90 ° C. .. The measurement results are shown in Table 10.
  • Example 26 Preparation of immobilized carrier of heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 24 was carried out except that the heat treatment conditions of the allergen extract were set to 80 ° C. .. The measurement results are shown in Table 10.
  • Comparative Example 16 Preparation of immobilized carrier of non-heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 24 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 10.
  • the value of the fluorescence intensity ratio (positive sample (class 5) / positive sample (class 4)) of the allergy class 5 positive sample to the allergy class 4 positive sample is also the value when the heat-treated allergen extract is used. It was shown to be larger than when the non-heat-treated product was used. That is, it was shown that the allergen class can be discriminated with high accuracy and the concentration of the specific IgE antibody can be measured by using the allergen extract after heat treatment.
  • Reference Example 4 Measurement of the amount of allergen immobilized on the carrier
  • a standard substrate in which a fixed amount of protein is immobilized on a PMMA resin substrate (protein amount per unit area between 0 mg / ⁇ m 2 and 9.5E- 12 mg / ⁇ m 2 ) 7 levels) were prepared, and a mass spectrum was obtained by the flight time type secondary ion mass analysis method. Of these, a calibration curve was created to calculate the fixed amount of protein per unit area from the intensity ratio of the protein-derived peak and the PMMA-derived peak.
  • Time-of-flight secondary ion mass spectrometry was performed on the test carrier, and the amount of protein immobilized per unit area was calculated from the intensity ratio of the peak derived from the allergen protein and the peak derived from PMMA using the calibration curve. ..
  • Measurement conditions Device TOF.
  • SIMS 5 manufactured by ION-TOF
  • Primary ion Bi 3 ++ Secondary ion polarity: Positive ions only.
  • Example 27 Measurement of allergen-immobilized amount of a carrier on which a heat-treated product of a crab allergen extract is immobilized The amount of allergen immobilized on an allergen-immobilized carrier for detecting a specific antibody of a crab allergen prepared in Example 1 , Measured by the method described in Reference Example 4. The results are shown in Table 11.
  • Comparative Example 17 Measurement of allergen-immobilized amount of a carrier on which a non-heat-treated product of a crab allergen extract was immobilized The amount of allergen immobilized on an allergen-immobilized carrier for detecting a specific antibody of a crab allergen prepared in Comparative Example 1. was measured by the method described in Reference Example 4. The results are shown in Table 11.
  • Example 28 Measurement of allergen-immobilized amount of a carrier on which a heat-treated product of a crab allergen extract is immobilized The amount of allergen immobilized on an allergen-immobilized carrier for detecting a specific antibody of a crab allergen prepared in Example 2 , Measured by the method described in Reference Example 4. The results are shown in Table 11.
  • Comparative Example 18 Measurement of allergen-immobilized amount of a carrier on which a non-heat-treated product of a crab allergen extract was immobilized The amount of allergen immobilized on an allergen-immobilized carrier for detecting a specific antibody of a crab allergen prepared in Comparative Example 2. was measured by the method described in Reference Example 4. The results are shown in Table 11.
  • Example 29 Preparation of immobilized carrier of heat-treated product of heated garlic allergen extract, measurement of allergen immobilization amount
  • the heated garlic allergen extract is diluted with PBS to a final concentration of 0.2 mg / mL, and the solution is 100 ⁇ L. Prepared in. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 TM was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
  • an allergen-immobilized carrier for detecting a specific antibody of the heated garlic allergen was prepared by the method described in Reference Example 2, and the amount of the immobilized allergen was shown in Reference Example 4. It was measured by the method described. The results are shown in Table 12.
  • Comparative Example 19 Preparation of an immobilized carrier of a non-heat-treated product of a heated garlic allergen extract and measurement of the amount of allergen-immobilized allergen extract by the same method as in Example 29 except that the heat treatment of the allergen extract was not performed.
  • An allergen-immobilized carrier for detecting a specific antibody of a heated garlic allergen was prepared, and the amount of the immobilized allergen was measured by the method described in Reference Example 4. The results are shown in Table 12.
  • Example 30 Preparation of immobilized carrier of heat-treated product of heated garlic allergen extract, measurement of allergen-immobilized amount SDS was added as a surfactant during heat treatment of allergen extract. For detection of specific antibody of heated garlic allergen by the same method as in Example 29 except that it was added to 20 mM sodium phosphate buffer (pH 7.0) so as to have a final concentration of 0.02% by volume.
  • the allergen-immobilized carrier of No. 1 was prepared, and the amount of the immobilized allergen was measured by the method described in Reference Example 4. The results are shown in Table 12.
  • the heated garlic allergen extract has already been heat-treated at the extraction stage (corresponding to the cooked garlic disclosed in Patent Document 1), but by the method of the present invention. It was shown that the amount of allergen immobilized on the carrier is increased by further heat-treating this and then immobilizing it.
  • Example 31 Preparation of immobilized carrier of heat-treated product of soybean allergen extract, measurement of allergen-specific antibody Soybean allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0) so as to have a final concentration of 1 mg / mL. It was dissolved and the solution was prepared to 100 ⁇ L. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 TM was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
  • Soybean allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0) so as to have a final concentration of 1 mg / mL. It was dissolved and the solution was prepared to 100 ⁇ L. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 TM was added so as to have a final concentration of 0.003%
  • an allergen-immobilized carrier for detecting a specific antibody of soybean allergen was prepared by the method described in Reference Example 2.
  • the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
  • soybean allergy-positive plasma was purchased from PlasmaLab and used.
  • plasma confirmed to be negative as a result of a soybean allergy test by SRL, Inc. was used.
  • Table 13 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
  • Comparative Example 20 Preparation of immobilized carrier of non-heat-treated soybean allergen extract, measurement of allergen-specific antibody The same method as in Example 31 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 13.
  • Example 32 Preparation of immobilized carrier of heat-treated product of soybean allergen extract, measurement of allergen-specific antibody SDS was added to 20 mM sodium phosphate buffer (pH 7.0) as a surfactant during heat treatment of allergen extract. The procedure was the same as in Example 31 except that the mixture was added so as to have a final concentration of 0.02% by volume. The measurement results are shown in Table 13.
  • Comparative Example 21 Preparation of immobilized carrier of non-heat-treated soybean allergen extract, measurement of allergen-specific antibody The same method as in Example 32 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 13.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Sustainable Development (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Disclosed are: a method for producing an allergen-immobilized carrier which is for an allergy examination and with which an allergen-specific antibody can be detected with high sensitivity; and a method for detecting an allergen-specific antibody using said carrier. The method for producing an allergen-immobilized carrier for detecting an allergen-specific antibody comprises: step [1] for heating an allergenic extract to obtain a heat-treated material of the allergenic extract; and step [2] for immobilizing, on a carrier, the heat-treated material obtained in step [1]. The method for detecting an allergen-specific antibody in a specimen comprises a step for bringing a specimen into contact with the allergen-immobilized carrier produced by said method, and detecting a specific antibody, in the specimen, which forms a complex with the allergen immobilized on the carrier.

Description

アレルゲン固定化担体の製造方法及びアレルゲン特異的抗体の検出方法Method for producing allergen-immobilized carrier and method for detecting allergen-specific antibody
 本発明は、アレルゲン特異的抗体を検出するためのアレルゲンが固定化された担体の製造方法及び当該アレルゲン固定化担体を用いるアレルゲン特異的抗体の検出方法に関する。 The present invention relates to a method for producing an allergen-immobilized carrier for detecting an allergen-specific antibody and a method for detecting an allergen-specific antibody using the allergen-immobilized carrier.
 体内には、細菌やウイルス等の異物が侵入してきた際、それらと結合する抗体が産生され、異物を排除して体を守る免疫機構が存在する。しかしながら、大部分の人には無害である異物、例えば花粉や食品、ダニなどに対しても、それらと結合する抗体が産生され、過剰に免疫を引き起こし、自分自身が傷害されるアレルギー反応を引き起こす体質の人が存在する。 When foreign substances such as bacteria and viruses invade the body, antibodies that bind to them are produced, and there is an immune system that eliminates the foreign substances and protects the body. However, even for foreign substances that are harmless to most people, such as pollen, food, and mites, antibodies that bind to them are produced, causing excessive immunity and causing allergic reactions that injure oneself. There is a person with a constitution.
 異物が体内に侵入するとIgM、IgG、IgA等様々な抗体が産生されるが、アレルギーの直接誘発に関わるのはIgE抗体であり、アレルギーの原因となるアレルゲンと特異的に結合するIgE抗体は特異的IgE抗体と呼ばれる。体内に侵入してきたアレルゲンと特異的IgE抗体が結合することで、肥満細胞などからヒスタミンを初めとした各種化学伝達物質が放出され、血管拡張、気管支平滑筋収縮、毛細血管透過性亢進などの作用により発赤や咳、鼻水等のアレルギー症状が現れる。症状が重い場合には呼吸困難、血圧低下などのショック症状によるアナフィラキシー反応が生じ、生命を脅かす危険な状態に陥ることもある。そのため、アレルギー症状の原因物質を特定し、治療に繋げたり、アレルゲンとの接触や摂取を避けたりすることでアレルギー症状を引き起こさないようにする必要がある。従ってアレルギーの検査は、高感度かつ正確に検出されることが強く望まれている。 When a foreign substance invades the body, various antibodies such as IgM, IgG, and IgA are produced, but it is the IgE antibody that is directly involved in the induction of allergies, and the IgE antibody that specifically binds to the allergen that causes allergies is specific. It is called an IgE antibody. When allergens that have invaded the body bind to specific IgE antibodies, various chemical messengers such as histamine are released from mast cells, etc., and have actions such as vasodilation, bronchial smooth muscle contraction, and increased permeability of capillaries. Allergic symptoms such as redness, cough, and nasal discharge appear. If the symptoms are severe, anaphylactic reactions due to shock symptoms such as dyspnea and decreased blood pressure may occur, leading to a life-threatening and dangerous condition. Therefore, it is necessary to identify the causative substance of allergic symptoms, connect it to treatment, and avoid contact with and ingestion of allergens to prevent allergic symptoms. Therefore, it is strongly desired that allergy tests be detected with high sensitivity and accuracy.
 アレルギー検査は、主に「皮膚テスト」、「経口負荷試験(食物アレルギー)」及び「血液検査」に大別される。 Allergy tests are mainly divided into "skin test", "oral stress test (food allergy)" and "blood test".
 皮膚テストは、花粉や食品、ダニ等の抽出物から希薄溶液を調製し、それらを皮膚に乗せて細い針で出血しない程度に指すもしくは引っかく(プリックテスト、スクラッチテスト)、または皮内に注射(皮内テスト)した際に膨疹を観察する方法である。皮膚テストは感度が高いものの、特異度が低いという問題があり、陰性・陽性の判別性能に問題がある。 In the skin test, a dilute solution is prepared from extracts such as pollen, food, and mites, placed on the skin and pointed or scratched with a fine needle to the extent that it does not bleed (prick test, scratch test), or injected intradermally (prick test, scratch test). This is a method of observing wheals during an intradermal test). Although the skin test has high sensitivity, it has a problem of low specificity, and there is a problem of negative / positive discrimination performance.
 また、食物アレルギーでは、皮内テストはショックの可能性や偽陽性率が高いため、アレルギーが確定しているか疑われている食品を少量摂取させ、アレルギー症状の有無を確認する検査である、経口負荷試験が実施される。しかし、この方法においても依然としてショックのリスクがあるため、緊急対応が十分可能な施設でのみの実施に限られる。 In addition, for food allergies, the intradermal test has a high possibility of shock and a high false positive rate, so it is a test to confirm the presence or absence of allergic symptoms by ingesting a small amount of food that is suspected to be allergic. A load test is performed. However, even with this method, there is still a risk of shock, so it is limited to implementation only in facilities where emergency response is sufficient.
 これに対し、血液検査によるアレルギー検査は、採血した血液中の好塩基球に花粉や食品、ダニ等の抽出物からの希薄溶液を反応させ、好塩基球から遊離してくるヒスタミンの量を測定する方法である(ヒスタミン遊離試験)。採血という低侵襲性の検査であり、生体内の反応を反映できるという利点が存在するが、症例の約20%に低反応を示すLow-Responderが存在し、これらはヒスタミン遊離試験の適用外となってしまう。また、冷蔵保存した血液を3日以内に検査する必要があるため、臨床現場では汎用されていない。 On the other hand, in the allergy test by blood test, the amount of histamine released from the basophils is measured by reacting the basophils in the collected blood with a dilute solution from extracts such as pollen, food and mites. (Histamine release test). It is a minimally invasive test called blood sampling, and has the advantage of being able to reflect in vivo reactions, but about 20% of cases have Low-Responders that show low reactions, and these are not applicable to the histamine release test. turn into. In addition, since it is necessary to test the refrigerated blood within 3 days, it is not widely used in clinical practice.
 現在、臨床現場で汎用的に実施されているアレルギー検査は、血液中の特異的IgE抗体の量を測定する方法である。 Currently, the allergy test that is generally performed in clinical practice is a method of measuring the amount of specific IgE antibody in blood.
 特異的IgE抗体の検出は、アレルゲンを担体に固定化したアレルゲン固定化担体を用意し、これに血液(血清・血漿)検体を反応させて、アレルゲンと結合する特異的IgE抗体を捕捉し、そのアレルゲンと特異的抗体との複合体を酵素や蛍光標識した抗IgE抗体を用いて検出することで行われている。臨床の現場で広く用いられている特異的IgE抗体検査法の具体例としては、サーモフィッシャーダイアグノスティックス株式会社のCAP(capsulated hydrophilic carrier polymer)法が挙げられる。 For the detection of specific IgE antibody, an allergen-immobilized carrier in which the allergen is immobilized on the carrier is prepared, and a blood (serum / plasma) sample is reacted with the allergen-immobilized carrier to capture the specific IgE antibody that binds to the allergen. This is done by detecting a complex of an allergen and a specific antibody using an enzyme or a fluorescently labeled anti-IgE antibody. A specific example of a specific IgE antibody test method widely used in clinical practice is the CAP (capsulated hydrophilic carrier polymer) method of Thermo Fisher Scientific Co., Ltd.
 非特許文献1には、CAP法の感度を向上させるために、多孔質のセルローススポンジにアレルゲンを固定化した担体を用い、表面積を増やすことで担体当たりのアレルゲン固定化量を多くする方法が記載されている。 Non-Patent Document 1 describes a method in which a carrier in which an allergen is immobilized on a porous cellulose sponge is used in order to improve the sensitivity of the CAP method, and the amount of allergen immobilized per carrier is increased by increasing the surface area. Has been done.
 また、特許文献1には、加熱した食品(にんにく)と加熱していない食品とからアレルゲンを抽出し、これらの抽出したアレルゲンを個別にスポットしたアレルギー診断用のチップが記載されている。 Further, Patent Document 1 describes a chip for allergy diagnosis in which allergens are extracted from a heated food (garlic) and an unheated food, and these extracted allergens are individually spotted.
特表2004-533625号公報Special Table 2004-533625
 近年ではアレルギーの種類が細分化されており、検査項目が増加する傾向にある。そのため、より少量の検体からでも高感度に検出可能な新たな方法が求められている。 In recent years, the types of allergies have been subdivided, and the number of test items tends to increase. Therefore, there is a demand for a new method that can detect with high sensitivity even from a smaller amount of sample.
 本発明は、このようなニーズに応えるものであり、アレルゲン特異的抗体を高い感度で検出可能なアレルギー検査用のアレルゲン固定化担体の製造方法及び当該担体を用いるアレルゲン特異的抗体の検出方法を提供するものである。 The present invention meets such needs, and provides a method for producing an allergen-immobilized carrier for an allergy test capable of detecting an allergen-specific antibody with high sensitivity, and a method for detecting an allergen-specific antibody using the carrier. To do.
 本発明者らは、上記課題を解決するため鋭意研究した結果、アレルギー検査用のアレルゲン固定化担体の製造において、アレルギー原材料から抽出したアレルゲン抽出物を加熱処理して、当該アレルゲン抽出物の加熱処理物を担体に固定化することにより、加熱処理を行わないアレルゲン抽出物を固定化した担体と比べて、固定化されるアレルゲン量が増加することを見出した。また、この方法により作製したアレルゲン固定化担体を用いることにより、従来より特異的抗体をより高感度に検出できることを見出し、本発明を完成させた。 As a result of diligent research to solve the above problems, the present inventors heat-treated the allergen extract extracted from the allergen raw material in the production of the allergen-immobilized carrier for allergy test, and heat-treated the allergen extract. It was found that by immobilizing the substance on the carrier, the amount of allergen immobilized is increased as compared with the carrier on which the allergen extract not subjected to the heat treatment is immobilized. Further, they have found that a specific antibody can be detected with higher sensitivity than before by using an allergen-immobilized carrier prepared by this method, and completed the present invention.
 本発明は、以下のものを提供する。 The present invention provides the following.
(1)アレルゲン特異的抗体を検出するためのアレルゲン固定化担体の製造方法であって、
アレルゲン抽出物を加熱してアレルゲン抽出物の加熱処理物を得る工程[1]、及び
前記工程[1]で得られた加熱処理物を担体に固定化する工程[2]
を含む、担体の製造方法。
(2)前記工程[1]の加熱温度は、60℃以上100℃未満である、(1)に記載の製造方法。
(3)前記特異的抗体が特異的IgE抗体である、(1)又は(2)に記載の製造方法。
(4)前記工程[2]において、前記加熱処理物が、前記担体に共有結合により固定化される(1)~(3)のいずれか1項に記載の方法。
(5)(1)~(4)のいずれかの方法により製造されたアレルゲン固定化担体に検体を接触させ、当該担体に固定化されたアレルゲンと複合体を形成した検体中の特異的抗体を検出する工程を含む、検体中のアレルゲン特異的抗体を検出する方法。
(1) A method for producing an allergen-immobilized carrier for detecting an allergen-specific antibody.
A step of heating the allergen extract to obtain a heat-treated product of the allergen extract [1], and a step of immobilizing the heat-treated product obtained in the above step [1] on a carrier [2].
A method for producing a carrier, including.
(2) The production method according to (1), wherein the heating temperature in the step [1] is 60 ° C. or higher and lower than 100 ° C.
(3) The production method according to (1) or (2), wherein the specific antibody is a specific IgE antibody.
(4) The method according to any one of (1) to (3), wherein in the step [2], the heat-treated product is immobilized on the carrier by a covalent bond.
(5) A sample is brought into contact with an allergen-immobilized carrier produced by any of the methods (1) to (4), and a specific antibody in the sample forming a complex with the allergen immobilized on the carrier is obtained. A method for detecting an allergen-specific antibody in a sample, which comprises a step of detecting.
 アレルギー検査用のアレルゲン固定化担体の製造において、アレルゲン抽出物を加熱処理後に固定化することにより、未加熱で用いた場合より多くのアレルゲンが固定化されたアレルゲン固定化担体を得ることが可能となる。また、当該担体を用いることにより、少量の検体であっても高い感度でアレルゲン特異的抗体を検出することが可能となる。 In the production of an allergen-immobilized carrier for allergy testing, by immobilizing the allergen extract after heat treatment, it is possible to obtain an allergen-immobilized carrier in which more allergens are immobilized than when used without heating. Become. Further, by using the carrier, it becomes possible to detect an allergen-specific antibody with high sensitivity even with a small amount of sample.
 本発明で用いるアレルゲン抽出物は、アレルギー原材料に含まれるタンパク質を抽出したものである。 The allergen extract used in the present invention is an extract of a protein contained in an allergic raw material.
 アレルギー原材料は、アレルギーを引き起こすアレルゲンを含む材料の総称であり、具体的には、微生物、植物、動物、昆虫およびハウスダスト、並びにこれらが含まれる食品などが挙げられる。アレルギーを引き起こすか否かは、体質に依存する。 Allergy raw materials are a general term for materials containing allergens that cause allergies, and specific examples thereof include microorganisms, plants, animals, insects and house dust, and foods containing these. Whether or not it causes allergies depends on the constitution.
 アレルゲンを含む微生物の例としては、アルテルナリア、アスペルギルス、カンジダ、マラセチア、ダニなどが挙げられる。 Examples of microorganisms containing allergens include Alternaria, Aspergillus, Candida, Malassezia, and mites.
 アレルゲンを含む植物の例としては、スギ、ヒノキ、ハンノキ、シラカンバ、カモガヤ、ブタクサ、ヨモギおよびオオアワガエリ、並びにこれらの花粉などが挙げられる。 Examples of plants containing allergens include sugi, hinoki, alder, birch, Dactylis, ragweed, mugwort and timothy, and pollen of these.
 アレルゲンを含む動物の例としては、ネコ、イヌ、マウス、ラット、ハムスター、ウサギ、インコ、アヒルなどが挙げられる
 アレルゲンを含む昆虫の例としては、ガ、ゴキブリ、ハチなどが挙げられる。
Examples of animals containing allergens include cats, dogs, mice, rats, hamsters, rabbits, inco, ducks and the like. Examples of insects containing allergens include moths, cockroaches and bees.
 アレルゲンを含む食品の例としては、卵、牛乳、小麦、落花生、大豆、蕎麦、ゴマ、米、エビ、カニ、イカ、タコ、キウイ、バナナ、リンゴ、モモ、トマト、ニンニク、マグロ、鮭、サバ、牛肉、豚肉、鶏肉などが挙げられる。 Examples of foods containing allergens include eggs, milk, wheat, peanuts, soybeans, soba, sesame, rice, shrimp, crab, squid, octopus, kiwi, banana, apple, peach, tomato, garlic, tuna, salmon, mackerel. , Beef, pork, chicken and so on.
 アレルゲン抽出物は、市販されているものを用いてもよいし、自らアレルギー原材料から抽出したものを用いてもよい。市販のアレルゲン抽出物は、ITEA株式会社や、コスモバイオ株式会社などから購入することができる。アレルゲン抽出物の抽出方法は、特に限定されないが、公知の方法によって抽出すればよい。具体的には以下の方法で抽出することができる。 As the allergen extract, a commercially available one may be used, or one extracted from allergen raw materials by oneself may be used. Commercially available allergen extracts can be purchased from ITEA Inc., Cosmo Bio Co., Ltd., and the like. The method for extracting the allergen extract is not particularly limited, but it may be extracted by a known method. Specifically, it can be extracted by the following method.
 まず、アレルギー原材料を刻む又は凍結乾燥後に粉砕する等により細かくし、溶媒を添加してホモジェナイズし、4℃で一晩抽出した後に遠心分離して上清を得る。続いて、上清をろ紙やガーゼ、フィルターなどでろ過することを数回繰り返した後に遠心分離して上清を得る。さらに、その上清を緩衝液で透析したものや、さらに凍結乾燥させて得られたものを、本発明のアレルゲン抽出物として用いることができる。 First, the allergen raw material is finely chopped or crushed after freeze-drying, homogenized by adding a solvent, extracted overnight at 4 ° C., and then centrifuged to obtain a supernatant. Subsequently, the supernatant is filtered with a filter paper, gauze, a filter or the like several times, and then centrifuged to obtain a supernatant. Further, the supernatant obtained by dialyzing the supernatant with a buffer solution or further freeze-drying can be used as the allergen extract of the present invention.
 上記抽出方法において、抽出に用いる溶媒としては、イオン交換水、リン酸緩衝生理食塩水(PBS)、リン酸ナトリウム緩衝液、炭酸水素ナトリウム水溶液、トリス緩衝液、酢酸緩衝液、クエン酸緩衝液、炭酸緩衝液、Good‘s buffer、その他のタンパク質の溶解に適した溶液を用いればよい。これらの中でも、リン酸ナトリウム緩衝液、炭酸水素ナトリウム水溶液が溶媒として好ましく用いられる。また、アレルゲンの安定化のために、抽出の際にDimethyl sulfoxide(DMSO)、N,N-dimethylformamide(DMF)、グリセロールやメタノールまたはエタノールなどのアルコール、グルコース、フルクトース、トレハロースなどの糖類が添加されていてもよい。 In the above extraction method, the solvents used for extraction include ion-exchanged water, phosphate buffered saline (PBS), sodium phosphate buffer, sodium hydrogen carbonate aqueous solution, Tris buffer, acetate buffer, and citrate buffer. A carbonate buffer, Good's buffer, or other solution suitable for dissolving proteins may be used. Among these, sodium phosphate buffer solution and sodium hydrogen carbonate aqueous solution are preferably used as solvents. Further, in order to stabilize the allergen, saccharides such as Dimethyl sulfoxide (DMSO), N, N-dimethylformamide (DMF), alcohols such as glycerol, methanol or ethanol, glucose, fructose and trehalose are added at the time of extraction. You may.
 本発明で用いるアレルゲン抽出物は、粗抽出物であってもよいし、粗抽出物を精製した精製物であってもよい。粗抽出物を精製する方法の例としては、例えば、脂質の多いアレルギー原材料の場合、これを凍結乾燥後に粉砕した後、ヘキサンで処理し、ペレットを得て乾燥させることで脂質を除去する方法、イオン交換クロマトグラフィ、ゲルクロマトグラフィまたは限外濾過などにより不純物を除去したり、特定のタンパク質を単離したりする方法などが挙げられる。 The allergen extract used in the present invention may be a crude extract or a purified product obtained by purifying the crude extract. An example of a method for purifying a crude extract is, for example, in the case of an allergic raw material containing a large amount of lipid, a method of removing lipid by freeze-drying, pulverizing, treating with hexane, obtaining pellets and drying. Examples thereof include a method of removing impurities by ion exchange chromatography, gel chromatography, ultrafiltration and the like, and isolation of a specific protein.
 本発明は、アレルゲン抽出物を加熱処理した後に担体に固定化することを特徴とする。アレルゲン抽出物の加熱処理温度は60℃以上100℃未満が好ましく、より好ましくは80℃以上100℃未満、最も好ましくは、80℃以上95℃以下である。加熱時間は、処理するアレルゲン抽出物の量に応じて適宜設定することができるが、好ましくは1分以上である。加熱時間の上限は特になく、加熱時間は例えば60分間以下、特には30分以下であるが、通常10分であれば十分である。 The present invention is characterized in that the allergen extract is heat-treated and then immobilized on a carrier. The heat treatment temperature of the allergen extract is preferably 60 ° C. or higher and lower than 100 ° C., more preferably 80 ° C. or higher and lower than 100 ° C., and most preferably 80 ° C. or higher and 95 ° C. or lower. The heating time can be appropriately set according to the amount of the allergen extract to be treated, but is preferably 1 minute or more. There is no particular upper limit to the heating time, and the heating time is, for example, 60 minutes or less, particularly 30 minutes or less, but usually 10 minutes is sufficient.
 アレルゲン抽出物の加熱処理は、アレルゲン抽出物を液体に溶解させて行うことが好ましい。アレルゲン抽出物の溶解液には、上記のアレルゲンの抽出で用いる溶媒を用いることができる。市販のアレルゲン抽出物を用いる場合等、アレルゲンの抽出で用いる溶媒が不明な場合等では、アレルゲン抽出物を溶解する液体としては、リン酸緩衝生理食塩水(PBS)、イオン交換水、リン酸ナトリウム緩衝液、炭酸水素ナトリウム水溶液、トリス緩衝液、酢酸緩衝液、クエン酸緩衝液、炭酸緩衝液、Good‘s buffer、その他のタンパク質の溶解に適した溶媒を用いることができる。 The heat treatment of the allergen extract is preferably performed by dissolving the allergen extract in a liquid. As the solution of the allergen extract, the solvent used in the above allergen extraction can be used. When the solvent used for extracting the allergen is unknown, such as when a commercially available allergen extract is used, the liquid for dissolving the allergen extract is phosphate buffered saline (PBS), ion-exchanged water, or sodium phosphate. A solvent suitable for dissolving a buffer solution, an aqueous sodium hydrogen carbonate solution, a Tris buffer solution, an acetate buffer solution, a citrate buffer solution, a carbonate buffer solution, Good's buffer, and other proteins can be used.
 アレルゲン抽出物の加熱処理は、界面活性剤の共存下で実施してもよい。界面活性剤はタンパク質の可溶化作用や熱処理時の凝固防止作用があるため、好ましく用いられる。また、加熱処理されたアレルゲン抽出物を担体に固定化させる場合に、界面活性剤が存在することで濡れ性が向上し、均一な固定化が可能となる。なお、濡れ性が向上して均一な固定化が可能となるという効果は、加熱処理後に界面活性剤を添加した場合にでも得ることができるので、加熱処理を界面活性剤の非存在下で行う場合でも、加熱処理後に界面活性剤を添加することも好ましい。 The heat treatment of the allergen extract may be carried out in the presence of a surfactant. Surfactants are preferably used because they have a protein solubilizing effect and a coagulation preventing effect during heat treatment. Further, when the heat-treated allergen extract is immobilized on the carrier, the presence of the surfactant improves the wettability and enables uniform immobilization. The effect of improving wettability and enabling uniform immobilization can be obtained even when a surfactant is added after the heat treatment, so that the heat treatment is performed in the absence of the surfactant. Even in this case, it is also preferable to add a surfactant after the heat treatment.
 界面活性剤には、アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤、ノニオン界面活性剤などの種類があるが、いずれも好ましく用いることができる。アニオン界面活性剤として、ドデシル硫酸ナトリウム(SDS)などが挙げられる。両性界面活性剤として、3-[(3-Cholamidopropyl)dimethylammonio]propanesulfonate(CHAPS)、3-[(3-Cholamidopropyl)dimethylammonio)-2-hydroxypropanesulfonate(CHAPSO)などが挙げられる。ノニオン界面活性剤として、Triton X-100(商標)、Triton X-114(商標)、NP-40、Brij-35、Brij-58、Tween20(商標)、Tween80(商標)、Octyl Glucoside、Octyl thioglucosideなどが挙げられる。これらの中でも、SDSやTween20(商標)が特に好ましく用いられる。界面活性剤の濃度が高すぎると、加熱処理されたアレルゲン抽出物が特異的IgE抗体と結合できないほど変性させてしまうことがある。そのため、SDSやTween20(商標)を用いる場合は、アレルゲン抽出物の加熱処理を実施する溶液に対して、終濃度が0.001~0.1容量%となるように添加することが好ましく、特に0.003~0.05容量%となるように添加することが好ましい。 There are various types of surfactants such as anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants, all of which can be preferably used. Examples of the anionic surfactant include sodium dodecyl sulfate (SDS) and the like. Examples of amphoteric tenside agents include 3-[(3-Cholamidopropyl) dimethyramminio] propanesulfonate (CHAPS) and 3-[(3-Cholamidoplopyl) dimethyramminio) -2-hydropypropanesulfone. Nonionic surfactants include Triton X-100 (trademark), Triton X-114 (trademark), NP-40, Brij-35, Brij-58, Tween20 (trademark), Tween80 (trademark), Octyl Glucside, Octyl thioglucoside, etc. Can be mentioned. Among these, SDS and Tween 20 ™ are particularly preferably used. If the concentration of the surfactant is too high, the heat-treated allergen extract may be denatured to the extent that it cannot bind to the specific IgE antibody. Therefore, when SDS or Tween 20 (trademark) is used, it is preferable to add the allergen extract to the solution to be heat-treated so that the final concentration is 0.001 to 0.1% by volume. It is preferable to add the mixture in an amount of 0.003 to 0.05% by volume.
 本発明の方法で製造されるアレルゲン固定化担体は、アレルゲン抽出物の加熱処理物を固定化した担体と検体とを接触させることにより、担体表面のアレルゲンと複合体を形成した、検体中に含まれる特異的IgE抗体等の特異的抗体を検出することができるものである。つまり、本発明の提供するアレルゲン固定化担体を用いると、検体中の、アレルゲンと複合体を形成する特異的抗体を検出することができる。 The allergen-immobilized carrier produced by the method of the present invention is contained in the sample, which forms a complex with the allergen on the surface of the carrier by contacting the sample with the carrier on which the heat-treated product of the allergen extract is immobilized. It is possible to detect a specific antibody such as a specific IgE antibody. That is, by using the allergen-immobilized carrier provided by the present invention, it is possible to detect a specific antibody that forms a complex with the allergen in the sample.
 複数のアレルゲン抽出物の加熱処理物が1つの担体上の複数箇所にそれぞれ固定化されており、各加熱処理物が検体と1つの反応場(後述)で接触反応させることができれば、より少量の検体から複数のアレルゲン特異的IgE抗体を同時検査できるので、より好ましい。 If heat-treated products of a plurality of allergen extracts are immobilized on a plurality of locations on one carrier, and each heat-treated product can be contacted with a sample in one reaction field (described later), a smaller amount is required. It is more preferable because a plurality of allergen-specific IgE antibodies can be simultaneously tested from the sample.
 アレルゲン抽出物の加熱処理物を固定化する担体の材料としては、ガラス、樹脂、金属、金属酸化物、ゲル、セルロース、炭素材料などが挙げられるが、固定化が可能な担体であればこれらに限定されない。担体の材料として用いられる樹脂には、ポリスチレン、ポリカーボネート、ポリエチレン、ポリプロピレン、ポリメチルメタクリレート、ポリエチレンテレフタレート、ポリエーテルスルホン、ポリブチレンテレフタレート、ポリブチレンスクシネート、ポリ乳酸、ポリアミド系樹脂、ABSなどを用いることができる。担体の材料として用いられる金属には、金、銀、銅、白金、チタン、パラジウム、鉄、アルミニウム、ニッケルまたはこれらの合金などを用いることができる。固相担体の材料として用いられる金属酸化物には、二酸化ケイ素、酸化アルミニウム、酸化セリウム、酸化ジルコニウム又は複合酸化物などを用いることができる。 Examples of the carrier material for immobilizing the heat-treated product of the allergen extract include glass, resin, metal, metal oxide, gel, cellulose, carbon material, etc., but any carrier capable of immobilization can be used. Not limited. As the resin used as the material of the carrier, polystyrene, polycarbonate, polyethylene, polypropylene, polymethylmethacrylate, polyethylene terephthalate, polyether sulfone, polybutylene terephthalate, polybutylene succinate, polylactic acid, polyamide resin, ABS and the like are used. be able to. As the metal used as the material of the carrier, gold, silver, copper, platinum, titanium, palladium, iron, aluminum, nickel, alloys thereof and the like can be used. As the metal oxide used as the material of the solid phase carrier, silicon dioxide, aluminum oxide, cerium oxide, zirconium oxide, composite oxide and the like can be used.
 担体の形状は、板状、薄膜、粒子状、多孔質状などから、適宜選択すればよいが、好ましくは板状である。板状の担体の材料には、射出成型による製造が可能な、ポリメチルメタクリレート、ポリスチレン、ポリプロピレンなどの樹脂材料が生産性の面から好ましい。 The shape of the carrier may be appropriately selected from plate-like, thin film, particle-like, porous, etc., but is preferably plate-like. As the material of the plate-shaped carrier, a resin material such as polymethylmethacrylate, polystyrene, or polypropylene, which can be produced by injection molding, is preferable from the viewpoint of productivity.
 アレルゲン抽出物の加熱処理物を担体に固定化する方法としては、物理吸着と化学結合があるが、化学的に固定化する方法が好ましい。また、化学的固定化の中でも共有結合による結合が好ましい。共有結合によって、担体にアレルゲン抽出物の加熱処理物を固定化させるためには、アレルゲン抽出物の加熱処理物と結合可能な官能基を有する担体を用いる。例えば、担体上に公知の方法でカルボキシル基を生成させることで、アレルゲン抽出物の加熱処理物のアミノ基と共有結合で固定化することができる。具体的には、担体がポリメチルメタクリレートなどのアクリル樹脂の場合には、以下の方法が挙げられる。担体の表面を苛性ソーダなどのアルカリ性水溶液によって加水分解処理し、カルボキシル基を樹脂表面に生成させた後、当該カルボキシル基と、アレルゲン抽出物の加熱処理物に含まれるアミノ基とを直接共有結合(アミド結合)させることにより固定化することができる。また、担体上に生成させたカルボキシル基に対し、エステル結合でマレイミド基を導入し、当該マレイミド基と、アレルゲン抽出物の加熱処理物に含まれるシステイン残基由来のチオール基とを共有結合させることにより固定化することもできる。なお、担体上のカルボキシル基にタンパク質を共有結合方法させる方法自体は周知であり、下記実施例にも具体的に記載されている。 As a method of immobilizing the heat-treated product of the allergen extract on the carrier, there are physical adsorption and chemical bond, but the method of chemically immobilizing is preferable. Further, among the chemical immobilizations, a bond by a covalent bond is preferable. In order to immobilize the heat-treated product of the allergen extract on the carrier by covalent bonding, a carrier having a functional group capable of binding to the heat-treated product of the allergen extract is used. For example, by generating a carboxyl group on the carrier by a known method, it can be covalently immobilized with the amino group of the heat-treated product of the allergen extract. Specifically, when the carrier is an acrylic resin such as polymethylmethacrylate, the following methods can be mentioned. The surface of the carrier is hydrolyzed with an alkaline aqueous solution such as caustic soda to generate a carboxyl group on the resin surface, and then the carboxyl group and the amino group contained in the heat-treated product of the allergen extract are directly covalently bonded (amide). It can be fixed by binding). In addition, a maleimide group is introduced into the carboxyl group generated on the carrier by an ester bond, and the maleimide group is covalently bonded to the thiol group derived from the cysteine residue contained in the heat-treated product of the allergen extract. It can also be fixed by. The method itself for covalently bonding a protein to a carboxyl group on a carrier is well known, and is specifically described in the following examples.
 また、アレルゲン抽出物の加熱処理物を共有結合により化学的に固定化する際には、アレルゲン抽出物の加熱処理物を溶媒に溶解させた状態で行うことができる。溶媒の具体例としては、リン酸緩衝生理食塩水(PBS)、イオン交換水、リン酸ナトリウム緩衝液、炭酸水素ナトリウム水溶液、トリス緩衝液、酢酸緩衝液、クエン酸緩衝液、炭酸緩衝液、Good‘s buffer、その他のタンパク質の溶解に適した溶媒を用いることができる。アレルゲン抽出物を溶解、加熱、担体への固定化まで一貫して同一の溶媒を用いることが可能な場合、途中で溶媒置換の操作が不要であり、アレルゲン抽出物の加熱処理物の固定化担体を製造する上で簡便な工程を採用することができるので好ましい。この場合の溶媒としては、PBS、リン酸ナトリウム緩衝液、炭酸水素ナトリウム水溶液が好ましく用いられる。 Further, when the heat-treated product of the allergen extract is chemically immobilized by a covalent bond, the heat-treated product of the allergen extract can be dissolved in a solvent. Specific examples of the solvent include phosphate buffered saline (PBS), ion-exchanged water, sodium phosphate buffer, sodium hydrogen carbonate aqueous solution, Tris buffer, acetate buffer, citrate buffer, carbonate buffer, Good. A solvent suitable for dissolving's buffer and other proteins can be used. If the same solvent can be used consistently from dissolving, heating, and immobilizing the allergen extract to the carrier, no solvent replacement operation is required on the way, and the immobilization carrier of the heat-treated product of the allergen extract is not required. It is preferable because a simple process can be adopted for producing the above. As the solvent in this case, PBS, sodium phosphate buffer solution, and sodium hydrogen carbonate aqueous solution are preferably used.
 アレルゲン抽出物の加熱処理物の溶液と担体とを接触させる方法としては、溶液に担体を浸漬させる方法や、担体に溶液を滴下する方法を用いることができる。アレルゲンと、検体が1つの反応場で同時に接触できるように固定化させれば、より少ない検体から複数のアレルギーを同時に検出することができるので、公知のスポッティング装置を用いて同一の板状担体上に複数のアレルゲン抽出物の加熱処理物の溶液をそれぞれスポッティングして固定化することが好ましい。ここで、アレルゲンと検体を「1つの反応場で接触させる」とは、複数のアレルゲン抽出物の加熱処理物がそれぞれ独立に隔壁なく固定化された担体に対して、検体を添加して接触させることであり、検体中の特異的抗体が、固定化されたいずれかのアレルゲン抽出物の加熱処理物と同じ空間で自由に接触できることを意味する。それぞれのアレルゲン抽出物の加熱処理物に結合した特異的抗体を検出することで、アレルギーの原因となる複数の特異的抗体を同時検出することができる。1つの反応場で1種類の特異的抗体が検出できるシステムと比較して、隔壁のない1つの反応場で反応、検出を行うことができれば、アレルギー1項目あたりの検査に必要な検体量を減らすことができる。 As a method of bringing the solution of the heat-treated product of the allergen extract into contact with the carrier, a method of immersing the carrier in the solution or a method of dropping the solution onto the carrier can be used. If the allergen and the sample are immobilized so that they can come into contact with each other at the same time in one reaction field, multiple allergies can be detected from a smaller number of samples at the same time. Therefore, on the same plate-like carrier using a known spotting device. It is preferable to spot and immobilize the solutions of the heat-treated products of the plurality of allergen extracts. Here, "contacting the allergen and the sample in one reaction field" means that the sample is added and brought into contact with a carrier in which heat-treated products of a plurality of allergen extracts are independently immobilized without partition walls. This means that the specific antibody in the sample can be freely contacted in the same space as the heat-treated product of any of the immobilized allergen extracts. By detecting the specific antibody bound to the heat-treated product of each allergen extract, it is possible to simultaneously detect a plurality of specific antibodies that cause allergies. Compared to a system that can detect one type of specific antibody in one reaction field, if the reaction and detection can be performed in one reaction field without a partition wall, the amount of sample required for testing per allergy item will be reduced. be able to.
 固定化されたアレルゲンの量は、担体表面のアレルゲンのタンパク質量を直接定量する方法、固定化されたアレルゲンを担体に酸や還元剤などを含む溶液を反応させて担体からアレルゲンを乖離させ、溶液中に存在するタンパク質量をBCA法やBradford法、紫外吸光高度法等により定量する方法のいずれも用いることができる。このうち、担体と共有結合、例えばアミド結合しているアレルゲンを担体から乖離させることは容易でないため、担体表面上のアレルゲンタンパク質量を直接定量する方法が好ましい。担体表面上のアレルゲンのタンパク質量を定量する方法としては、高速原子間力顕微鏡による観察や表面プラズモン共鳴法等が挙げられるが、担体が樹脂製の場合、飛行時間型2次イオン質量分析法を用いた定量法が好ましい。 The amount of immobilized allergen can be determined by a method of directly quantifying the amount of protein of the allergen on the surface of the carrier, or by reacting the immobilized allergen with a solution containing an acid or a reducing agent to dissociate the allergen from the carrier. Any method of quantifying the amount of protein present in the protein by the BCA method, the Bradford method, the ultraviolet absorption altitude method, or the like can be used. Of these, since it is not easy to disperse an allergen covalently bonded to the carrier, for example, an amide bond from the carrier, a method of directly quantifying the amount of allergen protein on the surface of the carrier is preferable. Examples of the method for quantifying the protein amount of the allergen on the surface of the carrier include observation with a high-speed atomic force microscope and surface plasmon resonance method. When the carrier is made of resin, time-of-flight secondary ion mass spectrometry is used. The quantitative method used is preferable.
 本発明で用いる検体は、体液由来のものが好ましい。体液は、血液、汗、尿、涙液、唾液、喀痰・気道分泌液、母乳、羊水、脳脊髄液、腹水、胸水、関節液、精液、膣分泌物などが挙げられるが、特異的IgE抗体等の特異的抗体が含まれる量が多い血液が好ましい。また、検体は、必要に応じて前処理を行ってもよい、例えば、血液の場合、血清や血漿も好ましく使用できる。 The sample used in the present invention is preferably derived from a body fluid. Body fluids include blood, sweat, urine, tears, saliva, sputum / airway secretions, breast milk, amniotic fluid, cerebrospinal fluid, ascites, pleural fluid, joint fluid, semen, vaginal discharge, etc., but specific IgE antibodies. Blood containing a large amount of specific antibodies such as the above is preferable. Further, the sample may be pretreated if necessary. For example, in the case of blood, serum or plasma can also be preferably used.
 本発明において、担体表面のアレルゲンと特異的抗体との複合体は、以下の方法で検出することができる。例えば、結合による屈折率差を検出原理とする表面プラズモン共鳴法や共振周波数差を検出原理とする水晶振動子マイクロバランス法などによる検出法が挙げられる。また、蛍光物質(蛍光色素)や、発色・発光物質を生成する酵素、放射性同位体元素等で修飾(標識)した抗IgE抗体などの二次抗体を用いる方法も挙げられる。これらの中でも、安全かつ簡便に取り扱いが可能な、蛍光物質で修飾した抗IgE抗体を用いる方法が好ましい。 In the present invention, the complex of the allergen on the surface of the carrier and the specific antibody can be detected by the following method. For example, a detection method using a surface plasmon resonance method based on a difference in refractive index due to coupling or a quartz crystal microbalance method using a difference in resonance frequency as a detection principle can be mentioned. Further, a method using a secondary antibody such as a fluorescent substance (fluorescent dye), an enzyme that produces a color-developing / luminescent substance, and an anti-IgE antibody modified (labeled) with a radioisotope element or the like can also be mentioned. Among these, a method using an anti-IgE antibody modified with a fluorescent substance, which is safe and easy to handle, is preferable.
 本発明の提供するアレルゲン固定化担体を用いて、アレルゲンと特異的抗体とにより形成された複合体を検出する場合には、特異的抗体の検出のみならず、特異的抗体の量を定量することもできる。特異的IgE抗体の定量には、蛍光物質を修飾した抗IgE抗体を用いることが好ましい。本発明の方法を用いて、検体に含まれる特異的IgE抗体の量を定量する具体的な方法は、以下の方法が挙げられる。 When detecting a complex formed by an allergen and a specific antibody using the allergen-immobilized carrier provided by the present invention, not only the detection of the specific antibody but also the amount of the specific antibody should be quantified. You can also. For the quantification of the specific IgE antibody, it is preferable to use an anti-IgE antibody modified with a fluorescent substance. Specific methods for quantifying the amount of specific IgE antibody contained in a sample using the method of the present invention include the following methods.
 特異的アレルギー診断における定量的免疫測定法では通常、世界保健機構IgE国際標準品(WHO International Standard immunoglobuline(IgE),human serum)を用いてまたは参照して、校正システムを構築する。この国際標準品は、ヒト血清由来の総IgE抗体のフリーズドライ試料であり(The 3rd International Standard for serum IgE: report of the international collaborative study to evaluate the candidate preparation: Geneva, 21 to 25 October 2013:WHO/BS/2013.2220)、例えば、これを用いて様々な濃度の総IgE抗体標準溶液を調製し、標準品と検体の測定値を比較することによって定量することができる。 Quantitative immunoassays in specific allergy diagnosis usually use or refer to the World Health Organization IgE International Standard (WHO International Standard immunoglobulin (IgE), human serum) to construct a calibration system. This international standard product is a freeze-dried sample of total IgE antibody derived from human serum (The 3rd International Standard for serum IgE: report of the international collaborative group 21 BS / 2013.2220), for example, can be used to prepare total IgE antibody standard solutions of various concentrations and quantified by comparing the measured values of the standard and the sample.
 本発明を以下の実施例によってさらに具体的に説明する。 The present invention will be described in more detail with reference to the following examples.
 <アレルゲン抽出物>
 以降の実施例と比較例に用いた各アレルゲンの抽出物は以下の購入先より入手し、またはアレルギー原材料より抽出して調製した。
<Allergen extract>
The extracts of each allergen used in the following Examples and Comparative Examples were obtained from the following purchasers or extracted from allergen raw materials.
 カニアレルゲン抽出物は鳥居薬品株式会社から購入した。ゴキブリアレルゲン抽出物はビオスタ社から購入した。ハンノキ花粉アレルゲン抽出物はITEA社より購入した。ブタクサアレルゲン抽出物は鳥居薬品株式会社から購入した。トマトアレルゲン抽出物は鳥居薬品株式会社から購入した。シラカンバ花粉アレルゲン抽出物はITEA社から購入した。ヒノキ花粉アレルゲン抽出物はITEA社から購入した。バナナアレルゲン抽出物はバナナをアレルギー原材料として参考例1の方法で作製した。加熱ニンニクアレルゲン抽出物は、生ニンニクを95℃で20分間加熱したものをアレルギー原材料として参考例1の方法で作製した。大豆アレルゲン抽出物はStallergenes Greer社から購入した。 The crab allergen extract was purchased from Torii Pharmaceutical Co., Ltd. The cockroach allergen extract was purchased from Biosuta. The alder pollen allergen extract was purchased from ITEA. The ragweed allergen extract was purchased from Torii Pharmaceutical Co., Ltd. The tomato allergen extract was purchased from Torii Pharmaceutical Co., Ltd. The birch pollen allergen extract was purchased from ITEA. The cypress pollen allergen extract was purchased from ITEA. The banana allergen extract was prepared by the method of Reference Example 1 using banana as an allergic raw material. The heated garlic allergen extract was prepared by heating raw garlic at 95 ° C. for 20 minutes as an allergen raw material by the method of Reference Example 1. The soybean allergen extract was purchased from Stallergenes Greer.
参考例1  アレルゲン抽出物の作製
 アレルギー原材料を細かくすりつぶし、3倍重量のPBSを添加して攪拌し、4℃で一晩抽出した後に遠心分離して上清を得た。続いて上清をろ紙でろ過し、さらに遠心分離して得た上清をPBSで透析し、アレルゲン抽出物を得た。
Reference Example 1 Preparation of allergen extract The allergen raw material was finely ground, 3 times the weight of PBS was added and stirred, and the mixture was extracted overnight at 4 ° C. and then centrifuged to obtain a supernatant. Subsequently, the supernatant was filtered through a filter paper, and the supernatant obtained by centrifugation was dialyzed against PBS to obtain an allergen extract.
参考例2  特異的抗体検出用のアレルゲン固定化担体の作製
 以降の実施例と比較例では、以下の方法で作製した特異的抗体検出用のアレルゲン固定化担体を用いた。
Reference Example 2 Preparation of allergen-immobilized carrier for specific antibody detection In the following Examples and Comparative Examples, an allergen-immobilized carrier for specific antibody detection prepared by the following method was used.
 担体としてポリメチルメタクリレート(PMMA)樹脂基板(クラレ製、外形75mm×25mm×1mm、平均分子量3万)を用いた。本基板を10規定の水酸化ナトリウムに70℃で14時間浸漬させた後、純水で3回洗浄し、乾燥した。このようにして、基板表面のPMMAの側鎖を加水分解して、カルボキシル基を生成した。次いで、50mM MES緩衝液(pH6)で3回基板を洗浄し、20%N,N-ジメチルホルムアミド(DMF)を含む50mM MES緩衝液(pH6)に1-エチル―3-(3-ジメチルアミノプロピル)カルボジイミド塩酸塩(EDC)(和光純薬社製)およびsulfo-N-hydroxysuccinimide(Sulfo-NHS)(和光純薬社製)が5重量%となるように調製した溶液に室温で1時間浸漬させた後、0.5mM塩酸で3回洗浄してNHSエステル化PMMA樹脂基板を得た。 A polymethylmethacrylate (PMMA) resin substrate (manufactured by Kuraray, outer diameter 75 mm × 25 mm × 1 mm, average molecular weight 30,000) was used as a carrier. The substrate was immersed in 10 specified sodium hydroxide at 70 ° C. for 14 hours, washed with pure water three times, and dried. In this way, the side chain of PMMA on the surface of the substrate was hydrolyzed to generate a carboxyl group. Then, the substrate was washed 3 times with 50 mM MES buffer (pH 6), and 1-ethyl-3- (3-dimethylaminopropyl) was added to 50 mM MES buffer (pH 6) containing 20% N, N-dimethylformamide (DMF). ) Carbodiimide hydrochloride (EDC) (manufactured by Wako Junyaku Co., Ltd.) and sulfo-N-hydroxysuccinimide (Sulfo-NHS) (manufactured by Wako Junyaku Co., Ltd.) are immersed in a solution prepared to have a concentration of 5% by weight at room temperature for 1 hour. Then, it was washed 3 times with 0.5 mM hydrochloric acid to obtain an NHS esterified PMMA resin substrate.
 次いで、各アレルゲン抽出物の加熱処理物(実施例)または非加熱処理物(比較例)を、スポッティング用ロボット(日本レーザー電子(株)、GTMASStamp-2)を用いて上記で作製した同一のNHSエステル化PMMA樹脂基板上に4点スポットした。次いで、基板を、密閉したプラスチック容器に入れて、37℃、湿度100%の条件で一晩インキュベートし、各アレルゲン抽出物の加熱処理物または非加熱処理物を固定化した。続いて、0.05%Tween20(商標)を含むPBS(PBST)で3回洗浄し、乾燥させて、特異的抗体検出用のアレルゲン固定化担体を得た。 Next, the same NHS produced above by using a spotting robot (Nippon Laser Electronics Co., Ltd., GTMASStammp-2) for the heat-treated product (Example) or non-heat-treated product (Comparative Example) of each allergen extract. Four spots were spotted on the esterified PMMA resin substrate. The substrate was then placed in a closed plastic container and incubated overnight at 37 ° C. and 100% humidity to immobilize heat-treated or non-heat-treated products of each allergen extract. Subsequently, the cells were washed 3 times with PBS (PBST) containing 0.05% Tween 20 ™ and dried to obtain an allergen-immobilized carrier for detecting specific antibodies.
参考例3  アレルゲン特異的抗体の検出
 以降の実施例及び比較例では、以下の方法で検体中に存在するアレルゲン特異的抗体を検出するため、蛍光色素で標識された抗IgE抗体を用いて蛍光強度を測定した。
Reference Example 3 Detection of Allergen-Specific Antibody In the following Examples and Comparative Examples, in order to detect the allergen-specific antibody present in the sample by the following method, a fluorescent dye-labeled anti-IgE antibody was used to detect the fluorescence intensity. Was measured.
 参考例2で作製した特異的抗体検出用のアレルゲン固定化担体を、1重量%ウシ血清アルブミン(BSA)(シグマアルドリッチ社製)を含むPBS溶液に4℃で一晩浸漬させてブロッキング処理したのち、PBSTで3回洗浄した。 The allergen-immobilized carrier for detecting specific antibodies prepared in Reference Example 2 was immersed in a PBS solution containing 1 wt% bovine serum albumin (BSA) (manufactured by Sigma-Aldrich) at 4 ° C. overnight for blocking treatment. , Washed 3 times with PBST.
 各検体10μLについて1重量%BSAを含むPBS水溶液で3倍希釈した溶液を、上記処理後の担体のアレルゲンが固定化されている部分に滴下し、ギャップカバーグラス(松波硝子工業株式会社製:24mm×25mm、ギャップサイズ20μm)を被せて封止した。37℃で2時間反応させた後、ギャップカバーグラスを外し、PBSTで3回洗浄した。次いで、1重量%BSAを含むPBSTで1000倍希釈した、Dylight-650色素標識抗ヒトIgEヤギポリクローナル抗体(Novus biologicals製)を30μL基板に添加し、ギャップカバーグラスを被せて室温で1時間反応させた。その後、ギャップカバーグラスを外し、PBSTで3回洗浄後に乾燥させて、スキャナー装置(東レ株式会社製、3D-GeneScanner3000)で蛍光強度を次の条件で測定した。 A solution diluted 3-fold with a PBS aqueous solution containing 1 wt% BSA for 10 μL of each sample was added dropwise to the portion of the carrier on which the allergen was immobilized, and a gap cover glass (manufactured by Matsunami Glass Industry Co., Ltd .: 24 mm) was added dropwise. It was sealed with a cover (× 25 mm, gap size 20 μm). After reacting at 37 ° C. for 2 hours, the gap cover glass was removed and washed 3 times with PBST. Next, a 30 μL substrate was added with a Dilight-650 dye-labeled anti-human IgE goat polyclonal antibody (manufactured by Novus biologicals) diluted 1000-fold with PBST containing 1 wt% BSA, covered with a gap cover glass, and reacted at room temperature for 1 hour. It was. Then, the gap cover glass was removed, washed with PBST three times, dried, and the fluorescence intensity was measured with a scanner device (3D-GeneScanner 3000 manufactured by Toray Industries, Inc.) under the following conditions.
蛍光強度測定条件
 装置:3D-GeneScanner3000(東レ製)
 励起光波長:635nm
 検出波長:670nm
 PMT:30。
Fluorescence intensity measurement condition Device: 3D-GeneScanner3000 (manufactured by Toray Industries, Inc.)
Excitation light wavelength: 635 nm
Detection wavelength: 670 nm
PMT: 30.
実施例1  カニアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 カニアレルゲン抽出物を、終濃度1mg/mLとなるよう20mMリン酸ナトリウム緩衝液(pH7.0)に溶解させ、溶液を100μLに調製した。続いて、溶液を95℃の加熱条件で10分間加熱処理を実施した。その後、Tween20(商標)を終濃度0.003容量%となるように添加して、アレルゲン抽出物の加熱処理物を得た。
Example 1 Preparation of immobilized carrier of heat-treated product of canial allergen extract, measurement of allergen-specific antibody The canial allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0) so as to have a final concentration of 1 mg / mL. It was dissolved and the solution was prepared to 100 μL. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 ™ was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
 このアレルゲン抽出物の加熱処理物を用いて、参考例2に記載の方法でカニアレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製した。 Using the heat-treated product of this allergen extract, an allergen-immobilized carrier for detecting a specific antibody of a crab allergen was prepared by the method described in Reference Example 2.
 このアレルゲン固定化担体を用いて、参考例3に記載の方法により、陽性検体および陰性検体の蛍光強度を測定し、アレルゲン特異的抗体を検出した。 Using this allergen-immobilized carrier, the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
 陽性検体として、PlasmaLab社よりカニアレルギー陽性血漿を購入して用いた。陰性検体としては、株式会社エスアールエルのカニアレルギー検査の結果陰性であることを確認した血漿を用いた。 As a positive sample, crab allergy-positive plasma was purchased from PlasmaLab and used. As a negative sample, plasma confirmed to be negative as a result of a crab allergy test by SRL, Inc. was used.
 参考例3に記載の方法により、蛍光強度を測定した結果と陰性検体の蛍光強度に対する陽性検体の蛍光強度の比(陽性検体/陰性検体)を表1に示す。なお、各測定値は、4点のスポットの測定値の平均値である。 Table 1 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
比較例1  カニアレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例1と同様の方法で実施した。測定結果を表1に示す。
Comparative Example 1 Preparation of an immobilized carrier of a non-heat-treated product of a crab allergen extract and measurement of an allergen-specific antibody The same method as in Example 1 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 1.
実施例2  カニアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理時に界面活性剤としてSDSを、20mMリン酸ナトリウム緩衝液(pH7.0)に終濃度0.02容量%となるように添加して用いたこと以外は、実施例1と同様の方法で実施した。測定結果を表1に示す。
Example 2 Preparation of immobilized carrier of heat-treated product of canial allergen extract, measurement of allergen-specific antibody SDS as a surfactant during heat treatment of allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0). The procedure was the same as in Example 1 except that the mixture was added so as to have a final concentration of 0.02% by volume. The measurement results are shown in Table 1.
比較例2  カニアレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例2と同様の方法で実施した。測定結果を表1に示す。
Comparative Example 2 Preparation of immobilized carrier of non-heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 2 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 1.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
 表1に示すとおり、カニアレルゲン抽出物を加熱処理することによって、陽性検体の蛍光強度が著しく上昇することがわかった。また、陰性検体については、アレルゲン抽出物の加熱処理の有無では大きな変化が見られなかった。さらに、アレルゲン抽出物を加熱処理することによって、陰性検体に対する陽性検体の蛍光強度比(陽性検体/陰性検体)が加熱処理しなかった場合に比べて大きくなることも確認された。以上のとおり、カニアレルゲン抽出物の加熱処理物を用いることで、カニに対する特異的IgE抗体を高い感度、高い特異度で検出できることが示された。 As shown in Table 1, it was found that the fluorescence intensity of the positive sample was significantly increased by heat-treating the crab allergen extract. In addition, for negative samples, no significant change was observed with or without heat treatment of the allergen extract. Furthermore, it was also confirmed that by heat-treating the allergen extract, the fluorescence intensity ratio (positive sample / negative sample) of the positive sample to the negative sample became larger than that in the case where the heat treatment was not performed. As described above, it was shown that the specific IgE antibody against crab can be detected with high sensitivity and high specificity by using the heat-treated product of the crab allergen extract.
実施例3  ゴキブリアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 ゴキブリアレルゲン抽出物を、終濃度1mg/mLとなるよう20mMリン酸ナトリウム緩衝液(pH7.0)に溶解させ、溶液を100μLに調製した。続いて、溶液を95℃の加熱条件で10分間加熱処理を実施した。その後、Tween20(商標)を終濃度0.003容量%となるように添加して、アレルゲン抽出物の加熱処理物を得た。
Example 3 Preparation of immobilized carrier of heat-treated product of gokibrial allergen extract, measurement of allergen-specific antibody The gokibrial allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0) to a final concentration of 1 mg / mL. It was dissolved and the solution was prepared to 100 μL. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 ™ was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
 このアレルゲン抽出物の加熱処理物を用いて、参考例2に記載の方法でゴキブリアレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製した。 Using the heat-treated product of this allergen extract, an allergen-immobilized carrier for detecting a specific antibody of a cockroach allergen was prepared by the method described in Reference Example 2.
 このアレルゲン固定化担体を用いて、参考例3に記載の方法により、陽性検体および陰性検体の蛍光強度を測定し、アレルゲン特異的抗体を検出した。 Using this allergen-immobilized carrier, the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
 陽性検体として、PlasmaLab社よりゴキブリアレルギー陽性血漿を購入して用いた。陰性検体としては、株式会社エスアールエルのゴキブリアレルギー検査の結果陰性であることを確認した血漿を用いた。 As a positive sample, cockroach allergy positive plasma was purchased from PlasmaLab and used. As a negative sample, plasma confirmed to be negative as a result of a cockroach allergy test by SRL, Inc. was used.
 参考例3に記載の方法により、蛍光強度を測定した結果と陰性検体の蛍光強度に対する陽性検体の蛍光強度の比(陽性検体/陰性検体)を表2に示す。なお、各測定値は、4点のスポットの測定値の平均値である。 Table 2 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
実施例4  ゴキブリアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理条件を60℃にしたこと以外は、実施例3と同様の方法で実施した。測定結果を表2に示す。
Example 4 Preparation of immobilized carrier of heat-treated product of cockroach allergen extract, measurement of allergen-specific antibody The same method as in Example 3 was carried out except that the heat treatment condition of the allergen extract was set to 60 ° C. .. The measurement results are shown in Table 2.
比較例3  ゴキブリアレルゲン抽出物の非加熱理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例3と同様の方法で実施した。測定結果を表2に示す。
Comparative Example 3 Preparation of a non-heated immobilized carrier of cockroach allergen extract and measurement of allergen-specific antibody The same method as in Example 3 was carried out except that the allergen extract was not heat-treated. .. The measurement results are shown in Table 2.
実施例5  ゴキブリアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理時に界面活性剤としてSDSを、20mMリン酸ナトリウム緩衝液(pH7.0)に終濃度0.02容量%となるように添加して用いたこと以外は、実施例3と同様の方法で実施した。測定結果を表2に示す。
Example 5 Preparation of immobilized carrier of heat-treated product of gokibrial allergen extract, measurement of allergen-specific antibody SDS as a surfactant during heat treatment of allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0). The procedure was the same as in Example 3 except that the mixture was added so as to have a final concentration of 0.02% by volume. The measurement results are shown in Table 2.
実施例6  ゴキブリアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理条件を60℃にしたこと以外は、実施例5と同様の方法で実施した。測定結果を表2に示す。
Example 6 Preparation of immobilized carrier of heat-treated product of cockroach allergen extract, measurement of allergen-specific antibody The same method as in Example 5 was carried out except that the heat treatment condition of the allergen extract was set to 60 ° C. .. The measurement results are shown in Table 2.
比較例4  ゴキブリアレルゲン抽出物の非加熱理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例5と同様の方法で実施した。測定結果を表2に示す。
Comparative Example 4 Preparation of a non-heated immobilized carrier of cockroach allergen extract and measurement of allergen-specific antibody The same method as in Example 5 was carried out except that the allergen extract was not heat-treated. .. The measurement results are shown in Table 2.
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
 表2に示すとおり、ゴキブリアレルゲン抽出物を加熱処理することによって、陽性検体の蛍光強度が著しく上昇することがわかった。また、陰性検体については、アレルゲン抽出物の加熱処理の有無では大きな変化が見られなかった。さらに、アレルゲン抽出物を加熱処理することによって、陰性検体に対する陽性検体の蛍光強度比(陽性検体/陰性検体)が加熱処理しなかった場合に比べて大きくなることも確認された。以上のとおり、ゴキブリアレルゲン抽出物の加熱処理物を用いることで、ゴキブリに対する特異的IgE抗体を高い感度、高い特異度で検出できることが示された。 As shown in Table 2, it was found that the fluorescence intensity of the positive sample was significantly increased by heat-treating the cockroach allergen extract. In addition, for negative samples, no significant change was observed with or without heat treatment of the allergen extract. Furthermore, it was also confirmed that by heat-treating the allergen extract, the fluorescence intensity ratio (positive sample / negative sample) of the positive sample to the negative sample became larger than that in the case where the heat treatment was not performed. As described above, it was shown that the specific IgE antibody against cockroach can be detected with high sensitivity and high specificity by using the heat-treated product of the cockroach allergen extract.
実施例7  ハンノキ花粉アレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 ハンノキ花粉アレルゲン抽出物を、終濃度1mg/mLとなるよう20mMリン酸ナトリウム緩衝液(pH7.0)に溶解させ、溶液を100μLに調製した。続いて、溶液を95℃の加熱条件で10分間加熱処理を実施した。その後、Tween20(商標)を、終濃度0.003容量%となるよう添加して、アレルゲン抽出物の加熱処理物を得た。
Example 7 Preparation of immobilized carrier of heat-treated product of Hannoki pollen allergen extract, measurement of allergen-specific antibody 20 mM sodium phosphate buffer (pH 7.0) so that the final concentration of Hannoki pollen allergen extract is 1 mg / mL. ) To prepare the solution to 100 μL. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 ™ was added to a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
 このアレルゲン抽出物の加熱処理物を用いて、参考例2に記載の方法でハンノキ花粉アレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製した。 Using the heat-treated product of this allergen extract, an allergen-immobilized carrier for detecting a specific antibody of alder pollen allergen was prepared by the method described in Reference Example 2.
 このアレルゲン固定化担体を用いて、参考例3に記載の方法により、陽性検体および陰性検体の蛍光強度を測定し、アレルゲン特異的抗体を検出した。 Using this allergen-immobilized carrier, the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
 陽性検体として、PlasmaLab社よりハンノキ花粉アレルギー陽性血漿を購入して用いた。陰性検体としては、株式会社エスアールエルのハンノキ花粉アレルギー検査の結果陰性であることを確認した血漿を用いた。 As a positive sample, alder pollen allergy-positive plasma was purchased from PlasmaLab and used. As a negative sample, plasma confirmed to be negative as a result of the alder pollen allergy test of SRL, Inc. was used.
 参考例3に記載の方法により、蛍光強度を測定した結果と陰性検体の蛍光強度に対する陽性検体の蛍光強度の比(陽性検体/陰性検体)を表3に示す。なお、各測定値は、4点のスポットの測定値の平均値である。 Table 3 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
実施例8  ハンノキ花粉アレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理条件を60℃にしたこと以外は、実施例7と同様の方法で実施した。測定結果を表3に示す。
Example 8 Preparation of immobilized carrier of heat-treated product of alder pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 7 was carried out except that the heat treatment condition of the allergen extract was set to 60 ° C. did. The measurement results are shown in Table 3.
比較例5  ハンノキ花粉アレルゲン抽出物の非加熱理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例7と同様の方法で実施した。測定結果を表3に示す。
Comparative Example 5 Preparation of a non-heated immobilized carrier of alder pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 7 was carried out except that the allergen extract was not heat-treated. did. The measurement results are shown in Table 3.
実施例9  ハンノキ花粉アレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理時に界面活性剤としてSDSを、20mMリン酸ナトリウム緩衝液(pH7.0)に終濃度0.02容量%となるように添加して用いたこと以外は、実施例7と同様の方法で実施した。測定結果を表3に示す。
Example 9 Preparation of immobilized carrier of heat-treated product of Hannoki pollen allergen extract, measurement of allergen-specific antibody SDS was used as a surfactant during heat treatment of allergen extract, and 20 mM sodium phosphate buffer (pH 7.0). It was carried out in the same manner as in Example 7 except that it was added and used so as to have a final concentration of 0.02% by volume. The measurement results are shown in Table 3.
実施例10  ハンノキ花粉アレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理条件を60℃にしたこと以外は、実施例9と同様の方法で実施した。測定結果を表3に示す。
Example 10 Preparation of immobilized carrier of heat-treated product of alder pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 9 was carried out except that the heat treatment condition of the allergen extract was set to 60 ° C. did. The measurement results are shown in Table 3.
比較例6  ハンノキ花粉アレルゲン抽出物の非加熱理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例9と同様の方法で実施した。測定結果を表3に示す。
Comparative Example 6 Preparation of non-heated immobilized carrier of alder pollen allergen extract, measurement of allergen-specific antibody Performed in the same manner as in Example 9 except that the allergen extract was not heat-treated. did. The measurement results are shown in Table 3.
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
 表3に示すとおり、ハンノキ花粉アレルゲン抽出物を加熱処理することによって、陽性検体の蛍光強度が著しく上昇することがわかった。また、陰性検体については、アレルゲン抽出物の加熱処理の有無では大きな変化が見られなかった。さらに、アレルゲン抽出物を加熱処理することによって、陰性検体に対する陽性検体の蛍光強度比(陽性検体/陰性検体)が加熱処理しなかった場合に比べて大きくなることも確認された。以上のとおり、ハンノキ花粉アレルゲン抽出物の加熱処理物を用いることで、ハンノキ花粉に対する特異的IgE抗体を高い感度、高い特異度で検出できることが示された。 As shown in Table 3, it was found that the fluorescence intensity of the positive sample was significantly increased by heat-treating the alder pollen allergen extract. In addition, for negative samples, no significant change was observed with or without heat treatment of the allergen extract. Furthermore, it was also confirmed that by heat-treating the allergen extract, the fluorescence intensity ratio (positive sample / negative sample) of the positive sample to the negative sample became larger than that in the case where the heat treatment was not performed. As described above, it was shown that the specific IgE antibody against alder pollen can be detected with high sensitivity and high specificity by using the heat-treated product of the alder pollen allergen extract.
実施例11  ブタクサ花粉アレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 ブタクサ花粉アレルゲン抽出物を、終濃度1mg/mLとなるよう20mMリン酸ナトリウム緩衝液(pH7.0)に溶解させ、溶液を100μLに調製した。続いて、溶液を95℃の加熱条件で10分間加熱処理を実施した。その後、Tween20(商標)を終濃度0.003容量%となるように添加して、アレルゲン抽出物の加熱処理物を得た。
Example 11 Preparation of immobilized carrier of heat-treated product of ragweed pollen allergen extract, measurement of allergen-specific antibody 20 mM sodium phosphate buffer (pH 7.0) so that the final concentration of ragweed pollen allergen extract is 1 mg / mL. ) To prepare the solution to 100 μL. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 ™ was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
 このアレルゲン抽出物の加熱処理物を用いて、参考例2に記載の方法でブタクサ花粉アレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製した。 Using the heat-treated product of this allergen extract, an allergen-immobilized carrier for detecting a specific antibody of ragweed pollen allergen was prepared by the method described in Reference Example 2.
 このアレルゲン固定化担体を用いて、参考例3に記載の方法により、陽性検体および陰性検体の蛍光強度を測定し、アレルゲン特異的抗体を検出した。 Using this allergen-immobilized carrier, the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
 陽性検体として、Abbaltis社よりブタクサ花粉アレルギー陽性血漿を購入して用いた。陰性検体としては、株式会社エスアールエルのブタクサ花粉アレルギー検査の結果陰性であることを確認した血漿を用いた。参考例3に記載の方法により、蛍光強度を測定した結果と陰性検体の蛍光強度に対する陽性検体の蛍光強度の比(陽性検体/陰性検体)を表4に示す。なお、各測定値は、4点のスポットの測定値の平均値である。 As a positive sample, ragweed pollen allergy-positive plasma was purchased from Abbaltis and used. As a negative sample, plasma confirmed to be negative as a result of the ragweed pollen allergy test of SRL, Inc. was used. Table 4 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
比較例7  ブタクサ花粉アレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例11と同様の方法で実施した。測定結果を表4に示す。
Comparative Example 7 Preparation of immobilized carrier of non-heat-treated product of ragweed pollen allergen extract, measurement of allergen-specific antibody Performed in the same manner as in Example 11 except that the heat treatment of the allergen extract was not performed. did. The measurement results are shown in Table 4.
実施例12  ブタクサ花粉アレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理時に界面活性剤としてSDSを、20mMリン酸ナトリウム緩衝液(pH7.0)に終濃度0.02容量%となるように添加して用いたこと以外は、実施例11と同様の方法で実施した。測定結果を表4に示す。
Example 12 Preparation of immobilized carrier of heat-treated product of ragweed pollen allergen extract, measurement of allergen-specific antibody SDS was used as a surfactant during heat treatment of allergen extract, and 20 mM sodium phosphate buffer (pH 7.0). It was carried out in the same manner as in Example 11 except that it was added and used so as to have a final concentration of 0.02% by volume. The measurement results are shown in Table 4.
比較例8  ブタクサ花粉アレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例12と同様の方法で実施した。測定結果を表4に示す。
Comparative Example 8 Preparation of immobilized carrier of non-heat-treated product of ragweed pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 12 was carried out except that the heat treatment of the allergen extract was not carried out. did. The measurement results are shown in Table 4.
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004
 表4に示すとおり、ブタクサ花粉アレルゲン抽出物を加熱処理することによって、陽性検体の蛍光強度が著しく上昇することがわかった。また、陰性検体については、アレルゲン抽出物の加熱処理の有無では大きな変化が見られなかった。さらに、アレルゲン抽出物を加熱処理することによって、陰性検体に対する陽性検体の蛍光強度比(陽性検体/陰性検体)が加熱処理しなかった場合に比べて大きくなることも確認された。以上のとおり、ブタクサ花粉アレルゲン抽出物の加熱処理物を用いることで、ブタクサ花粉に対する特異的IgE抗体を高い感度、高い特異度で検出できることが示された。 As shown in Table 4, it was found that the fluorescence intensity of the positive sample was significantly increased by heat-treating the ragweed pollen allergen extract. In addition, for negative samples, no significant change was observed with or without heat treatment of the allergen extract. Furthermore, it was also confirmed that by heat-treating the allergen extract, the fluorescence intensity ratio (positive sample / negative sample) of the positive sample to the negative sample became larger than that in the case where the heat treatment was not performed. As described above, it was shown that the specific IgE antibody against ragweed pollen can be detected with high sensitivity and high specificity by using the heat-treated product of the ragweed pollen allergen extract.
実施例13  トマトアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 トマトアレルゲン抽出物を、終濃度1mg/mLとなるよう20mMリン酸ナトリウム緩衝液(pH7.0)に溶解させ、溶液を100μLに調製した。続いて、溶液を95℃の加熱条件で10分間加熱処理を実施した。その後、Tween20(商標)を終濃度0.003容量%となるように添加して、アレルゲン抽出物の加熱処理物を得た。
Example 13 Preparation of immobilized carrier of heat-treated product of tomato allergen extract, measurement of allergen-specific antibody Put the tomato allergen extract in 20 mM sodium phosphate buffer (pH 7.0) so as to have a final concentration of 1 mg / mL. It was dissolved and the solution was prepared to 100 μL. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 ™ was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
 このアレルゲン抽出物の加熱処理物を用いて、参考例2に記載の方法でトマトアレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製した。 Using the heat-treated product of this allergen extract, an allergen-immobilized carrier for detecting a specific antibody of tomato allergen was prepared by the method described in Reference Example 2.
 このアレルゲン固定化担体を用いて、参考例3に記載の方法により、陽性検体および陰性検体の蛍光強度を測定し、アレルゲン特異的抗体を検出した。 Using this allergen-immobilized carrier, the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
 陽性検体として、PlasmaLab社よりトマトアレルギー陽性血漿を購入して用いた。陰性検体としては、株式会社エスアールエルのトマトアレルギー検査の結果陰性であることを確認した血漿を用いた。 As a positive sample, tomato allergy-positive plasma was purchased from PlasmaLab and used. As a negative sample, plasma confirmed to be negative as a result of a tomato allergy test by SRL, Inc. was used.
 参考例3に記載の方法により、蛍光強度を測定した結果と陰性検体の蛍光強度に対する陽性検体の蛍光強度の比(陽性検体/陰性検体)を表5に示す。なお、各測定値は、4点のスポットの測定値の平均値である。 Table 5 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
比較例9  トマトアレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例13と同様の方法で実施した。
Comparative Example 9 Preparation of immobilized carrier of non-heat-treated tomato allergen extract, measurement of allergen-specific antibody The same method as in Example 13 was carried out except that the allergen extract was not heat-treated. ..
実施例14  トマトアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理時に界面活性剤としてSDSを添加した。20mMリン酸ナトリウム緩衝液(pH7.0)に終濃度0.02容量%となるようSDSを添加して用いたこと以外は、実施例13と同様の方法で実施した。
Example 14 Preparation of immobilized carrier of heat-treated product of tomato allergen extract, measurement of allergen-specific antibody SDS was added as a surfactant during heat treatment of allergen extract. The procedure was the same as in Example 13 except that SDS was added to a 20 mM sodium phosphate buffer solution (pH 7.0) so as to have a final concentration of 0.02% by volume.
比較例10  トマトアレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例14と同様の方法で実施した。
Comparative Example 10 Preparation of an immobilized carrier of a non-heat-treated tomato allergen extract and measurement of allergen-specific antibody The same method as in Example 14 was carried out except that the allergen extract was not heat-treated. ..
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005
 表5に示すとおり、トマトアレルゲン抽出物を加熱処理することによって、陽性検体の蛍光強度が著しく上昇することがわかった。また、陰性検体については、アレルゲン抽出物の加熱処理の有無では大きな変化が見られなかった。さらに、アレルゲン抽出物を加熱処理することによって、陰性検体に対する陽性検体の蛍光強度比(陽性検体/陰性検体)が加熱処理しなかった場合に比べて大きくなることも確認された。以上のとおり、トマトアレルゲン抽出物の加熱処理物を用いることで、トマトに対する特異的IgE抗体を高い感度、高い特異度で検出できることが示された。 As shown in Table 5, it was found that the fluorescence intensity of the positive sample was significantly increased by heat-treating the tomato allergen extract. In addition, for negative samples, no significant change was observed with or without heat treatment of the allergen extract. Furthermore, it was also confirmed that by heat-treating the allergen extract, the fluorescence intensity ratio (positive sample / negative sample) of the positive sample to the negative sample became larger than that in the case where the heat treatment was not performed. As described above, it was shown that the specific IgE antibody against tomato can be detected with high sensitivity and high specificity by using the heat-treated product of the tomato allergen extract.
実施例15  シラカンバ花粉アレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 シラカンバ花粉アレルゲン抽出物を、終濃度1mg/mLとなるよう0.02容量%SDSを含む20mMリン酸ナトリウム緩衝液(pH7.0)に溶解させ、溶液を100μLに調製した。続いて、溶液を95℃の加熱条件で10分間加熱処理を実施した。その後、Tween20(商標)を終濃度0.003容量%となるように添加して、アレルゲン抽出物の加熱処理物を得た。
Example 15 Preparation of immobilized carrier of heat-treated product of Shirakamba pollen allergen extract, measurement of allergen-specific antibody 20 mM phosphorus containing 0.02% by volume SDS of Shirakamba pollen allergen extract to a final concentration of 1 mg / mL. It was dissolved in sodium acid buffer (pH 7.0) to prepare 100 μL of the solution. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 ™ was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
 このアレルゲン抽出物の加熱処理物を用いて、参考例2に記載の方法でシラカンバ花粉アレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製した。 Using the heat-treated product of this allergen extract, an allergen-immobilized carrier for detecting a specific antibody of the birch pollen allergen was prepared by the method described in Reference Example 2.
 前記シラカンバ花粉アレルゲンの特異的アレルゲン固定化担体を用いて、参考例3に記載の方法により、陽性検体および陰性検体の蛍光強度を測定し、アレルゲン特異的抗体を検出した。 Using the specific allergen-immobilized carrier of the birch pollen allergen, the fluorescence intensity of the positive sample and the negative sample was measured by the method described in Reference Example 3, and the allergen-specific antibody was detected.
 陽性検体として、PlasmaLab社よりシラカンバ花粉アレルギー陽性血漿を購入して用いた。陰性検体としては、株式会社エスアールエルのシラカンバ花粉アレルギー検査の結果陰性であることを確認した血漿を用いた。 As a positive sample, birch pollen allergy-positive plasma was purchased from PlasmaLab and used. As a negative sample, plasma confirmed to be negative as a result of the birch pollen allergy test of SRL, Inc. was used.
 参考例3に記載の方法により、蛍光強度を測定した結果と陰性検体の蛍光強度に対する陽性検体の蛍光強度の比(陽性検体/陰性検体)を表6に示す。なお、各測定値は、4点のスポットの測定値の平均値である。 Table 6 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
実施例16  シラカンバ花粉アレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理条件を60℃にしたこと以外は、実施例15と同様の方法で実施した。測定結果を表6に示す。
Example 16 Preparation of immobilized carrier of heat-treated product of birch pollen pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 15 was carried out except that the heat treatment condition of the allergen extract was set to 60 ° C. did. The measurement results are shown in Table 6.
比較例11  シラカンバ花粉アレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例15と同様の方法で実施した。測定結果を表6に示す。
Comparative Example 11 Preparation of immobilized carrier of non-heat-treated birch pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 15 was carried out except that the allergen extract was not heat-treated. did. The measurement results are shown in Table 6.
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000006
 表6に示すとおり、シラカンバ花粉アレルゲン抽出物を加熱処理することによって、陽性検体の蛍光強度が著しく上昇することがわかった。また、陰性検体については、アレルゲン抽出物の加熱処理の有無では大きな変化が見られなかった。さらに、アレルゲン抽出物を加熱処理することによって、陰性検体に対する陽性検体の蛍光強度比(陽性検体/陰性検体)が加熱処理しなかった場合に比べて大きくなることも確認された。以上のとおり、シラカンバ花粉アレルゲン抽出物の加熱処理物を用いることで、シラカンバ花粉に対する特異的IgE抗体を高い感度、高い特異度で検出できることが示された。 As shown in Table 6, it was found that the fluorescence intensity of the positive sample was significantly increased by heat-treating the birch pollen allergen extract. In addition, for negative samples, no significant change was observed with or without heat treatment of the allergen extract. Furthermore, it was also confirmed that by heat-treating the allergen extract, the fluorescence intensity ratio (positive sample / negative sample) of the positive sample to the negative sample became larger than that in the case where the heat treatment was not performed. As described above, it was shown that the specific IgE antibody against birch pollen can be detected with high sensitivity and high specificity by using the heat-treated product of the birch pollen allergen extract.
実施例17  ヒノキ花粉アレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 ヒノキ花粉アレルゲン抽出物を、終濃度1mg/mLとなるよう20mMリン酸ナトリウム緩衝液(pH7.0)に溶解させ、溶液を100μLに調製した。続いて、溶液を95℃の加熱条件で10分間加熱処理を実施した。その後、Tween20(商標)を終濃度0.003容量%となるよう添加して、アレルゲン抽出物の加熱処理物を得た。
Example 17 Preparation of immobilized carrier of heat-treated product of hinoki pollen allergen extract, measurement of allergen-specific antibody 20 mM sodium phosphate buffer (pH 7.0) so that the final concentration of hinoki pollen allergen extract is 1 mg / mL. ) To prepare the solution to 100 μL. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 ™ was added to a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
 このアレルゲン抽出物の加熱処理物を用いて、参考例2に記載の方法でヒノキ花粉アレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製した。 Using the heat-treated product of this allergen extract, an allergen-immobilized carrier for detecting a specific antibody of hinoki pollen allergen was prepared by the method described in Reference Example 2.
 このアレルゲン固定化担体を用いて、参考例3に記載の方法により、陽性検体および陰性検体の蛍光強度を測定し、アレルゲン特異的抗体を検出した。 Using this allergen-immobilized carrier, the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
 陽性検体として、Abbaltis社よりヒノキ花粉アレルギー陽性血漿を購入して用いた。陰性検体としては、株式会社エスアールエルのヒノキ花粉アレルギー検査の結果陰性であることを確認した血漿を用いた。 As a positive sample, hinoki pollen allergy-positive plasma was purchased from Abbaltis and used. As a negative sample, plasma confirmed to be negative as a result of the hinoki pollen allergy test of SRL, Inc. was used.
 参考例3に記載の方法により、蛍光強度を測定した結果と陰性検体の蛍光強度に対する陽性検体の蛍光強度の比(陽性検体/陰性検体)を表7に示す。なお、各測定値は、4点のスポットの測定値の平均値である。 Table 7 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
実施例18  ヒノキ花粉アレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理条件を60℃にしたこと以外は、実施例17と同様の方法で実施した。測定結果を表7に示す。
Example 18 Preparation of immobilized carrier of heat-treated product of hinoki pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 17 was carried out except that the heat treatment condition of the allergen extract was set to 60 ° C. did. The measurement results are shown in Table 7.
比較例12  ヒノキ花粉アレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例17と同様の方法で実施した。測定結果を表7に示す。
Comparative Example 12 Preparation of immobilized carrier of non-heat-treated hinoki pollen allergen extract, measurement of allergen-specific antibody The same method as in Example 17 was carried out except that the heat treatment of the allergen extract was not carried out. did. The measurement results are shown in Table 7.
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000007
 表7に示すとおり、ヒノキ花粉アレルゲン抽出物を加熱処理することによって、陽性検体の蛍光強度が著しく上昇することがわかった。また、陰性検体については、アレルゲン抽出物の加熱処理の有無では大きな変化が見られなかった。さらに、アレルゲン抽出物を加熱処理することによって、陰性検体に対する陽性検体の蛍光強度比(陽性検体/陰性検体)が加熱処理しなかった場合に比べて大きくなることも確認された。以上のとおり、ヒノキ花粉アレルゲン抽出物の加熱処理物を用いることで、ヒノキ花粉に対する特異的IgE抗体を高い感度、高い特異度で検出できることが示された。 As shown in Table 7, it was found that the fluorescence intensity of the positive sample was significantly increased by heat-treating the hinoki pollen allergen extract. In addition, for negative samples, no significant change was observed with or without heat treatment of the allergen extract. Furthermore, it was also confirmed that by heat-treating the allergen extract, the fluorescence intensity ratio (positive sample / negative sample) of the positive sample to the negative sample became larger than that in the case where the heat treatment was not performed. As described above, it was shown that the specific IgE antibody against hinoki cypress pollen can be detected with high sensitivity and high specificity by using the heat-treated product of the hinoki cypress pollen allergen extract.
実施例19  バナナアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 バナナアレルゲン抽出物を、終濃度1mg/mLとなるようPBSで希釈し、溶液を100μLに調製した。続いて、溶液を95℃の加熱条件で10分間加熱処理を実施した。その後、Tween20(商標)を終濃度0.003容量%となるように添加して、アレルゲン抽出物の加熱処理物を得た。
Example 19 Preparation of immobilized carrier of heat-treated product of banana allergen extract, measurement of allergen-specific antibody The banana allergen extract was diluted with PBS to a final concentration of 1 mg / mL, and the solution was prepared to 100 μL. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 ™ was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
 前記アレルゲン抽出物の加熱処理物を用いて、参考例2に記載の方法でバナナアレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製した。 Using the heat-treated product of the allergen extract, an allergen-immobilized carrier for detecting a specific antibody of a banana allergen was prepared by the method described in Reference Example 2.
 前記バナナアレルゲンの特異的アレルゲン固定化担体を用いて、参考例3に記載の方法により、陽性検体および陰性検体の蛍光強度を測定し、アレルゲン特異的抗体を検出した。 Using the banana allergen-specific allergen-immobilized carrier, the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
 陽性検体として、PlasmaLab社よりバナナアレルギー陽性血漿を購入して用いた。陰性検体としては、株式会社エスアールエルのバナナアレルギー検査の結果陰性であることを確認した血漿を用いた。 As a positive sample, banana allergy-positive plasma was purchased from PlasmaLab and used. As a negative sample, plasma confirmed to be negative as a result of a banana allergy test by SRL, Inc. was used.
 参考例3に記載の方法により、蛍光強度を測定した結果と陰性検体の蛍光強度に対する陽性検体の蛍光強度の比(陽性検体/陰性検体)を表8に示す。なお、各測定値は、4点のスポットの測定値の平均値である。 Table 8 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
比較例13  バナナアレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例19と同様の方法で実施した。測定結果を表8に示す。
Comparative Example 13 Preparation of immobilized carrier of non-heat-treated banana allergen extract, measurement of allergen-specific antibody The same method as in Example 19 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 8.
実施例20  バナナアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理時に界面活性剤としてSDSを、20mMリン酸ナトリウム緩衝液(pH7.0)に終濃度0.02容量%となるように添加して用いたこと以外は、実施例19と同様の方法で実施した。測定結果を表8に示す。
Example 20 Preparation of immobilized carrier of heat-treated banana allergen extract, measurement of allergen-specific antibody SDS was added to 20 mM sodium phosphate buffer (pH 7.0) as a surfactant during heat treatment of allergen extract. The procedure was the same as in Example 19 except that the mixture was added so as to have a final concentration of 0.02% by volume. The measurement results are shown in Table 8.
比較例14  バナナアレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例20と同様の方法で実施した。測定結果を表8に示す。
Comparative Example 14 Preparation of an immobilized carrier of a non-heat-treated banana allergen extract and measurement of allergen-specific antibody The same method as in Example 20 was carried out except that the allergen extract was not heat-treated. .. The measurement results are shown in Table 8.
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000008
 表8に示すとおり、バナナアレルゲン抽出物を加熱処理することによって、陽性検体の蛍光強度が著しく上昇することがわかった。また、陰性検体については、アレルゲン抽出物の加熱処理の有無では大きな変化が見られなかった。さらに、アレルゲン抽出物を加熱処理することによって、陰性検体に対する陽性検体の蛍光強度比(陽性検体/陰性検体)が加熱処理しなかった場合に比べて大きくなることも確認された。以上のとおり、バナナアレルゲン抽出物の加熱処理物を用いることで、バナナに対する特異的IgE抗体を高い感度、高い特異度で検出できることが示された。 As shown in Table 8, it was found that the fluorescence intensity of the positive sample was significantly increased by heat-treating the banana allergen extract. In addition, for negative samples, no significant change was observed with or without heat treatment of the allergen extract. Furthermore, it was also confirmed that by heat-treating the allergen extract, the fluorescence intensity ratio (positive sample / negative sample) of the positive sample to the negative sample became larger than that in the case where the heat treatment was not performed. As described above, it was shown that the specific IgE antibody against banana can be detected with high sensitivity and high specificity by using the heat-treated product of the banana allergen extract.
実施例21  カニアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 カニアレルゲン抽出物を、終濃度1mg/mLとなるよう20mMリン酸ナトリウム緩衝液(pH7.0)に溶解させ、溶液を100μLに調製した。続いて、溶液を95℃の加熱条件で10分間加熱処理を実施した。その後、Tween20(商標)を終濃度0.003容量%となるように添加して、アレルゲン抽出物の加熱処理物を得た。
Example 21 Preparation of immobilized carrier of heat-treated product of canial allergen extract, measurement of allergen-specific antibody The canial allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0) so as to have a final concentration of 1 mg / mL. It was dissolved and the solution was prepared to 100 μL. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 ™ was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
 このアレルゲン抽出物の加熱処理物を用いて、参考例2に記載の方法でカニアレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製した。 Using the heat-treated product of this allergen extract, an allergen-immobilized carrier for detecting a specific antibody of a crab allergen was prepared by the method described in Reference Example 2.
 このアレルゲン固定化担体を用いて、参考例3に記載の方法により、陽性検体および陰性検体の蛍光強度を測定し、アレルゲン特異的抗体を検出した。 Using this allergen-immobilized carrier, the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
 陽性検体として、アレルギークラス4のカニアレルギー陽性血漿と、アレルギークラス5のカニアレルギー陽性血漿をPlasmaLab社より入手して用いた。陰性検体としては、株式会社エスアールエルのカニアレルギー検査の結果陰性(アレルギークラス0)であることを確認した血漿を用いた。 As positive samples, allergy class 4 crab allergy positive plasma and allergy class 5 crab allergy positive plasma were obtained from PlasmaLab and used. As a negative sample, plasma confirmed to be negative (allergy class 0) as a result of a crab allergy test by SRL, Inc. was used.
 参考例3に記載の方法により、蛍光強度を測定した結果と陰性検体の蛍光強度に対する陽性検体の蛍光強度の比(陽性検体(クラス4)/陰性検体、陽性検体(クラス5)/陰性検体)、陽性検体同士の蛍光強度比(陽性検体(クラス5)/陽性検体(クラス4))を表9に示す。なお、各測定値は、4点のスポットの測定値の平均値である。 The ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample and the result of measuring the fluorescence intensity by the method described in Reference Example 3 (positive sample (class 4) / negative sample, positive sample (class 5) / negative sample) , Fluorescence intensity ratio between positive samples (positive sample (class 5) / positive sample (class 4)) is shown in Table 9. Each measured value is an average value of the measured values of the four spots.
実施例22  カニアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理条件を90℃にしたこと以外は、実施例21と同様の方法で実施した。測定結果を表9に示す。
Example 22 Preparation of immobilized carrier of heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 21 was carried out except that the heat treatment condition of the allergen extract was set to 90 ° C. .. The measurement results are shown in Table 9.
実施例23  カニアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理条件を80℃にしたこと以外は、実施例21と同様の方法で実施した。測定結果を表9に示す。
Example 23 Preparation of immobilized carrier of heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 21 was carried out except that the heat treatment conditions of the allergen extract were set to 80 ° C. .. The measurement results are shown in Table 9.
比較例15  カニアレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例21と同様の方法で実施した。測定結果を表9に示す。
Comparative Example 15 Preparation of immobilized carrier of non-heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 21 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 9.
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000009
 表9に示すとおり、カニレルゲン抽出物を加熱処理することによって、陽性検体の蛍光強度が著しく上昇することがわかった。また、陰性検体については、アレルゲン抽出物の加熱処理の有無では大きな変化が見られなかった。さらに、アレルゲン抽出物を加熱処理することによって、陰性検体に対する陽性検体の蛍光強度比(陽性検体/陰性検体)が加熱処理しなかった場合に比べて大きくなることが確認された。以上のとおり、カニアレルゲン抽出物の加熱処理物を用いることで、カニに対する特異的IgE抗体を高い感度、高い特異度で検出できることが示された。 As shown in Table 9, it was found that the fluorescence intensity of the positive sample was significantly increased by heat-treating the canylergen extract. In addition, for negative samples, no significant change was observed with or without heat treatment of the allergen extract. Furthermore, it was confirmed that by heat-treating the allergen extract, the fluorescence intensity ratio (positive sample / negative sample) of the positive sample to the negative sample became larger than that in the case where the heat treatment was not performed. As described above, it was shown that the specific IgE antibody against crab can be detected with high sensitivity and high specificity by using the heat-treated product of the crab allergen extract.
 また、アレルギークラス4の陽性検体に対するアレルギークラス5の陽性検体の蛍光強度比(陽性検体(クラス5)/陽性検体(クラス4))の値も、アレルゲン抽出物の加熱処理物を用いた場合は非加熱処理物を用いた場合と比べて大きくなることが示された。すなわち、アレルゲン抽出物を加熱処理して用いることにより、アレルギークラスを高精度に判別可能で、特異的IgE抗体の濃度も測定可能であることが示された。 In addition, the value of the fluorescence intensity ratio (positive sample (class 5) / positive sample (class 4)) of the allergy class 5 positive sample to the allergy class 4 positive sample is also the value when the heat-treated allergen extract is used. It was shown to be larger than when the non-heat-treated product was used. That is, it was shown that the allergen class can be discriminated with high accuracy and the concentration of the specific IgE antibody can be measured by using the allergen extract after heat treatment.
実施例24  カニアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理時に界面活性剤としてSDSを、20mMリン酸ナトリウム緩衝液pH7.0に終濃度0.02容量%となるように添加して用いたこと以外は、実施例21と同様の方法で実施した。測定結果を表10に示す。
Example 24 Preparation of immobilized carrier of heat-treated product of canial allergen extract, measurement of allergen-specific antibody SDS was added as a surfactant during heat treatment of allergen extract to a final concentration of 20 mM sodium phosphate buffer pH 7.0. It was carried out in the same manner as in Example 21 except that it was added and used so as to be 0.02% by volume. The measurement results are shown in Table 10.
実施例25  カニアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理条件を90℃にしたこと以外は、実施例24と同様の方法で実施した。測定結果を表10に示す。
Example 25 Preparation of immobilized carrier of heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 24 was carried out except that the heat treatment conditions of the allergen extract were set to 90 ° C. .. The measurement results are shown in Table 10.
実施例26  カニアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理条件を80℃にしたこと以外は、実施例24と同様の方法で実施した。測定結果を表10に示す。
Example 26 Preparation of immobilized carrier of heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 24 was carried out except that the heat treatment conditions of the allergen extract were set to 80 ° C. .. The measurement results are shown in Table 10.
比較例16  カニアレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例24と同様の方法で実施した。測定結果を表10に示す。
Comparative Example 16 Preparation of immobilized carrier of non-heat-treated product of crab allergen extract, measurement of allergen-specific antibody The same method as in Example 24 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 10.
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000010
 表10に示すとおり、カニアレルゲン抽出物を加熱処理することによって、陽性検体の蛍光強度が著しく上昇することがわかった。また、陰性検体については、アレルゲン抽出物の加熱処理の有無では大きな変化が見られなかった。さらに、アレルゲン抽出物を加熱処理することによって、陰性検体に対する陽性検体の蛍光強度比(陽性検体/陰性検体)が加熱処理しなかった場合に比べて大きくなることが確認された。以上のとおり、カニアレルゲン抽出物の加熱処理物を用いることで、カニに対する特異的IgE抗体を高い感度、高い特異度で検出できることが示された。 As shown in Table 10, it was found that the fluorescence intensity of the positive sample was significantly increased by heat-treating the crab allergen extract. In addition, for negative samples, no significant change was observed with or without heat treatment of the allergen extract. Furthermore, it was confirmed that by heat-treating the allergen extract, the fluorescence intensity ratio (positive sample / negative sample) of the positive sample to the negative sample became larger than that in the case where the heat treatment was not performed. As described above, it was shown that the specific IgE antibody against crab can be detected with high sensitivity and high specificity by using the heat-treated product of the crab allergen extract.
 また、アレルギークラス4の陽性検体に対するアレルギークラス5の陽性検体の蛍光強度比(陽性検体(クラス5)/陽性検体(クラス4))の値も、アレルゲン抽出物の加熱処理物を用いた場合は非加熱処理物を用いた場合と比べて大きくなることが示された。すなわち、アレルゲン抽出物を加熱処理して用いることにより、アレルギークラスを高精度に判別可能で、特異的IgE抗体の濃度も測定可能であることが示された。 In addition, the value of the fluorescence intensity ratio (positive sample (class 5) / positive sample (class 4)) of the allergy class 5 positive sample to the allergy class 4 positive sample is also the value when the heat-treated allergen extract is used. It was shown to be larger than when the non-heat-treated product was used. That is, it was shown that the allergen class can be discriminated with high accuracy and the concentration of the specific IgE antibody can be measured by using the allergen extract after heat treatment.
参考例4  担体に固定化されたアレルゲン量の測定
 PMMA樹脂基板上にタンパク質が一定量固定された標準基板(単位面積当たりのタンパク質量0mg/μmから9.5E-12mg/μm間で7水準)を作成し、飛行時間型2次イオン質量分析法により、質量スペクトルを得た。このうち、タンパク質由来のピークとPMMA由来のピークの強度比から単位面積当たりに固定されたタンパク質量を算出する検量線を作成した。
Reference Example 4 Measurement of the amount of allergen immobilized on the carrier A standard substrate in which a fixed amount of protein is immobilized on a PMMA resin substrate (protein amount per unit area between 0 mg / μm 2 and 9.5E- 12 mg / μm 2 ) 7 levels) were prepared, and a mass spectrum was obtained by the flight time type secondary ion mass analysis method. Of these, a calibration curve was created to calculate the fixed amount of protein per unit area from the intensity ratio of the protein-derived peak and the PMMA-derived peak.
 被験担体について、飛行時間型2次イオン質量分析を実施し、アレルゲンタンパク質由来のピークとPMMA由来のピークの強度比から、前記検量線を用いて単位面積当たりに固定化されたタンパク質量を算出した。 Time-of-flight secondary ion mass spectrometry was performed on the test carrier, and the amount of protein immobilized per unit area was calculated from the intensity ratio of the peak derived from the allergen protein and the peak derived from PMMA using the calibration curve. ..
測定条件
 装置:TOF.SIMS 5(ION-TOF社製)
 1次イオン:Bi ++
 2次イオン極性:正イオンのみ。
Measurement conditions Device: TOF. SIMS 5 (manufactured by ION-TOF)
Primary ion: Bi 3 ++
Secondary ion polarity: Positive ions only.
実施例27  カニアレルゲン抽出物の加熱処理物を固定化した担体の、アレルゲン固定化量の測定
 実施例1で作製したカニアレルゲンの特異的抗体検出用のアレルゲン固定化担体に固定されたアレルゲン量を、参考例4に記載の方法で測定した。その結果を表11に示す。
Example 27 Measurement of allergen-immobilized amount of a carrier on which a heat-treated product of a crab allergen extract is immobilized The amount of allergen immobilized on an allergen-immobilized carrier for detecting a specific antibody of a crab allergen prepared in Example 1 , Measured by the method described in Reference Example 4. The results are shown in Table 11.
比較例17  カニアレルゲン抽出物の非加熱処理物を固定化した担体の、アレルゲン固定化量の測定
 比較例1で作製したカニアレルゲンの特異的抗体検出用のアレルゲン固定化担体に固定されたアレルゲン量を、参考例4に記載の方法で測定した。その結果を表11に示す。
Comparative Example 17 Measurement of allergen-immobilized amount of a carrier on which a non-heat-treated product of a crab allergen extract was immobilized The amount of allergen immobilized on an allergen-immobilized carrier for detecting a specific antibody of a crab allergen prepared in Comparative Example 1. Was measured by the method described in Reference Example 4. The results are shown in Table 11.
実施例28  カニアレルゲン抽出物の加熱処理物を固定化した担体の、アレルゲン固定化量の測定
 実施例2で作製したカニアレルゲンの特異的抗体検出用のアレルゲン固定化担体に固定されたアレルゲン量を、参考例4に記載の方法で測定した。その結果を表11に示す。
Example 28 Measurement of allergen-immobilized amount of a carrier on which a heat-treated product of a crab allergen extract is immobilized The amount of allergen immobilized on an allergen-immobilized carrier for detecting a specific antibody of a crab allergen prepared in Example 2 , Measured by the method described in Reference Example 4. The results are shown in Table 11.
比較例18  カニアレルゲン抽出物の非加熱処理物を固定化した担体の、アレルゲン固定化量の測定
 比較例2で作製したカニアレルゲンの特異的抗体検出用のアレルゲン固定化担体に固定されたアレルゲン量を、参考例4に記載の方法で測定した。その結果を表11に示す。
Comparative Example 18 Measurement of allergen-immobilized amount of a carrier on which a non-heat-treated product of a crab allergen extract was immobilized The amount of allergen immobilized on an allergen-immobilized carrier for detecting a specific antibody of a crab allergen prepared in Comparative Example 2. Was measured by the method described in Reference Example 4. The results are shown in Table 11.
Figure JPOXMLDOC01-appb-T000011
Figure JPOXMLDOC01-appb-T000011
 表11に示すとおり、カニアレルゲン抽出物を加熱処理することによって、担体に固定化されるアレルゲン量が増加することが示された。即ち、アレルゲン抽出物を加熱処理して固定化することで、非加熱処理物を用いる場合と比較して、より多くのアレルゲンが担体に固定されるため、アレルゲン特異的抗体をより高感度に検出できることができることがわかった。 As shown in Table 11, it was shown that the amount of allergen immobilized on the carrier was increased by heat-treating the crab allergen extract. That is, by heat-treating and immobilizing the allergen extract, more allergens are immobilized on the carrier as compared with the case where the non-heat-treated product is used, so that the allergen-specific antibody is detected with higher sensitivity. I found that I could do it.
実施例29  加熱ニンニクアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン固定化量の測定
 加熱ニンニクアレルゲン抽出物を、終濃度0.2mg/mLとなるようPBSで希釈し、溶液を100μLに調製した。続いて、溶液を95℃の加熱条件で10分間加熱処理を実施した。その後、Tween20(商標)を終濃度0.003容量%となるように添加して、アレルゲン抽出物の加熱処理物を得た。
Example 29 Preparation of immobilized carrier of heat-treated product of heated garlic allergen extract, measurement of allergen immobilization amount The heated garlic allergen extract is diluted with PBS to a final concentration of 0.2 mg / mL, and the solution is 100 μL. Prepared in. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 ™ was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
 このアレルゲン抽出物の加熱処理物を用いて、参考例2に記載の方法で加熱ニンニクアレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製し、固定化されたアレルゲン量を、参考例4に記載の方法で測定した。その結果を表12に示す。 Using the heat-treated product of this allergen extract, an allergen-immobilized carrier for detecting a specific antibody of the heated garlic allergen was prepared by the method described in Reference Example 2, and the amount of the immobilized allergen was shown in Reference Example 4. It was measured by the method described. The results are shown in Table 12.
比較例19  加熱ニンニクアレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン固定化量の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例29と同様の方法で、加熱ニンニクアレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製し、固定化されたアレルゲン量を、参考例4に記載の方法で測定した。その結果を表12に示す。
Comparative Example 19 Preparation of an immobilized carrier of a non-heat-treated product of a heated garlic allergen extract and measurement of the amount of allergen-immobilized allergen extract by the same method as in Example 29 except that the heat treatment of the allergen extract was not performed. An allergen-immobilized carrier for detecting a specific antibody of a heated garlic allergen was prepared, and the amount of the immobilized allergen was measured by the method described in Reference Example 4. The results are shown in Table 12.
実施例30  加熱ニンニクアレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン固定化量の測定
 アレルゲン抽出物の加熱処理時に界面活性剤としてSDSを、添加した。20mMリン酸ナトリウム緩衝液(pH7.0)に終濃度0.02容量%となるように添加して用いたこと以外は、実施例29と同様の方法で、加熱ニンニクアレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製し、固定化されたアレルゲン量を、参考例4に記載の方法で測定した。その結果を表12に示す。
Example 30 Preparation of immobilized carrier of heat-treated product of heated garlic allergen extract, measurement of allergen-immobilized amount SDS was added as a surfactant during heat treatment of allergen extract. For detection of specific antibody of heated garlic allergen by the same method as in Example 29 except that it was added to 20 mM sodium phosphate buffer (pH 7.0) so as to have a final concentration of 0.02% by volume. The allergen-immobilized carrier of No. 1 was prepared, and the amount of the immobilized allergen was measured by the method described in Reference Example 4. The results are shown in Table 12.
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000012
 表12に示すとおり、加熱ニンニクアレルゲン抽出物は、抽出段階で既に加熱処理がされているものである(特許文献1において開示されている火を通したニンニクに相当)が、本発明の方法によりこれをさらに加熱処理してから固定化することによって、担体に固定化されるアレルゲン量が増加することが示された。 As shown in Table 12, the heated garlic allergen extract has already been heat-treated at the extraction stage (corresponding to the cooked garlic disclosed in Patent Document 1), but by the method of the present invention. It was shown that the amount of allergen immobilized on the carrier is increased by further heat-treating this and then immobilizing it.
実施例31  大豆アレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 大豆アレルゲン抽出物を、終濃度1mg/mLとなるよう20mMリン酸ナトリウム緩衝液(pH7.0)に溶解させ、溶液を100μLに調製した。続いて、溶液を95℃の加熱条件で10分間加熱処理を実施した。その後、Tween20(商標)を終濃度0.003容量%となるように添加して、アレルゲン抽出物の加熱処理物を得た。
Example 31 Preparation of immobilized carrier of heat-treated product of soybean allergen extract, measurement of allergen-specific antibody Soybean allergen extract was added to 20 mM sodium phosphate buffer (pH 7.0) so as to have a final concentration of 1 mg / mL. It was dissolved and the solution was prepared to 100 μL. Subsequently, the solution was heat-treated for 10 minutes under heating conditions of 95 ° C. Then, Tween 20 ™ was added so as to have a final concentration of 0.003% by volume to obtain a heat-treated product of the allergen extract.
 このアレルゲン抽出物の加熱処理物を用いて、参考例2に記載の方法で大豆アレルゲンの特異的抗体検出用のアレルゲン固定化担体を作製した。 Using the heat-treated product of this allergen extract, an allergen-immobilized carrier for detecting a specific antibody of soybean allergen was prepared by the method described in Reference Example 2.
 このアレルゲン固定化担体を用いて、参考例3に記載の方法により、陽性検体および陰性検体の蛍光強度を測定し、アレルゲン特異的抗体を検出した。 Using this allergen-immobilized carrier, the fluorescence intensities of positive and negative samples were measured by the method described in Reference Example 3, and allergen-specific antibodies were detected.
 陽性検体として、PlasmaLab社より大豆アレルギー陽性血漿を購入して用いた。陰性検体としては、株式会社エスアールエルの大豆アレルギー検査の結果陰性であることを確認した血漿を用いた。 As a positive sample, soybean allergy-positive plasma was purchased from PlasmaLab and used. As a negative sample, plasma confirmed to be negative as a result of a soybean allergy test by SRL, Inc. was used.
 参考例3に記載の方法により、蛍光強度を測定した結果と陰性検体の蛍光強度に対する陽性検体の蛍光強度の比(陽性検体/陰性検体)を表13に示す。なお、各測定値は、4点のスポットの測定値の平均値である。 Table 13 shows the ratio of the fluorescence intensity of the positive sample to the fluorescence intensity of the negative sample (positive sample / negative sample) and the result of measuring the fluorescence intensity by the method described in Reference Example 3. Each measured value is an average value of the measured values of the four spots.
比較例20  大豆アレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例31と同様の方法で実施した。測定結果を表13に示す。
Comparative Example 20 Preparation of immobilized carrier of non-heat-treated soybean allergen extract, measurement of allergen-specific antibody The same method as in Example 31 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 13.
実施例32  大豆アレルゲン抽出物の加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理時に界面活性剤としてSDSを、20mMリン酸ナトリウム緩衝液(pH7.0)に終濃度0.02容量%となるように添加して用いたこと以外は、実施例31と同様の方法で実施した。測定結果を表13に示す。
Example 32 Preparation of immobilized carrier of heat-treated product of soybean allergen extract, measurement of allergen-specific antibody SDS was added to 20 mM sodium phosphate buffer (pH 7.0) as a surfactant during heat treatment of allergen extract. The procedure was the same as in Example 31 except that the mixture was added so as to have a final concentration of 0.02% by volume. The measurement results are shown in Table 13.
比較例21  大豆アレルゲン抽出物の非加熱処理物の固定化担体の作製、アレルゲン特異的抗体の測定
 アレルゲン抽出物の加熱処理を実施しなかったこと以外は、実施例32と同様の方法で実施した。測定結果を表13に示す。
Comparative Example 21 Preparation of immobilized carrier of non-heat-treated soybean allergen extract, measurement of allergen-specific antibody The same method as in Example 32 was carried out except that the heat treatment of the allergen extract was not carried out. .. The measurement results are shown in Table 13.
Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000013
 表13に示すとおり、大豆アレルゲン抽出物を加熱処理することによって、陽性検体の蛍光強度が著しく上昇することがわかった。また、陰性検体については、アレルゲン抽出物の加熱処理の有無では大きな変化が見られなかった。さらに、アレルゲン抽出物を加熱処理することによって、陰性検体に対する陽性検体の蛍光強度比(陽性検体/陰性検体)が加熱処理しなかった場合に比べて大きくなることも確認された。以上のとおり、大豆アレルゲン抽出物の加熱処理物を用いることで、大豆に対する特異的IgE抗体を高い感度、高い特異度で検出できることが示された。 As shown in Table 13, it was found that the fluorescence intensity of the positive sample was significantly increased by heat-treating the soybean allergen extract. In addition, for negative samples, no significant change was observed with or without heat treatment of the allergen extract. Furthermore, it was also confirmed that by heat-treating the allergen extract, the fluorescence intensity ratio (positive sample / negative sample) of the positive sample to the negative sample became larger than that in the case where the heat treatment was not performed. As described above, it was shown that specific IgE antibody against soybean can be detected with high sensitivity and high specificity by using a heat-treated product of soybean allergen extract.

Claims (5)

  1.  アレルゲン特異的抗体を検出するためのアレルゲン固定化担体の製造方法であって、
    アレルゲン抽出物を加熱してアレルゲン抽出物の加熱処理物を得る工程[1]、及び
    前記工程[1]で得られた加熱処理物を担体に固定化する工程[2]
    を含む、担体の製造方法。
    A method for producing an allergen-immobilized carrier for detecting an allergen-specific antibody.
    A step of heating the allergen extract to obtain a heat-treated product of the allergen extract [1], and a step of immobilizing the heat-treated product obtained in the above step [1] on a carrier [2].
    A method for producing a carrier, including.
  2.  前記工程[1]の加熱温度は、60℃以上100℃未満である、請求項1に記載の方法。 The method according to claim 1, wherein the heating temperature in the step [1] is 60 ° C. or higher and lower than 100 ° C.
  3.  前記アレルゲン特異的抗体がIgE抗体である、請求項1又は2に記載の方法。 The method according to claim 1 or 2, wherein the allergen-specific antibody is an IgE antibody.
  4.  前記工程[2]において、前記加熱処理物が、前記担体に共有結合により固定化される請求項1~3のいずれか1項に記載の方法。 The method according to any one of claims 1 to 3, wherein in the step [2], the heat-treated product is immobilized on the carrier by a covalent bond.
  5.  請求項1~4のいずれかの方法により製造されたアレルゲン固定化担体に検体を接触させ、当該担体に固定化されたアレルゲンと複合体を形成した検体中の特異的抗体を検出する工程を含む、検体中のアレルゲン特異的抗体を検出する方法。 The step includes contacting a sample with an allergen-immobilized carrier produced by the method according to any one of claims 1 to 4, and detecting a specific antibody in the sample forming a complex with the allergen immobilized on the carrier. , A method for detecting an allergen-specific antibody in a sample.
PCT/JP2020/027835 2019-07-25 2020-07-17 Method for producing allergen-immobilized carrier, and method for detecting allergen-specific antibody WO2021015123A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020569213A JP7510620B2 (en) 2019-07-25 2020-07-17 Method for producing allergen-immobilized carrier and method for detecting allergen-specific antibodies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019136987 2019-07-25
JP2019-136987 2019-07-25

Publications (1)

Publication Number Publication Date
WO2021015123A1 true WO2021015123A1 (en) 2021-01-28

Family

ID=74193670

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/027835 WO2021015123A1 (en) 2019-07-25 2020-07-17 Method for producing allergen-immobilized carrier, and method for detecting allergen-specific antibody

Country Status (1)

Country Link
WO (1) WO2021015123A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022158509A1 (en) * 2021-01-21 2022-07-28 東レ株式会社 Allergen-immobilized carrier and method for detecting allergen-specific antibody
WO2022211084A1 (en) * 2021-04-01 2022-10-06 富士レビオ株式会社 Method for treating biological sample

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0131546A2 (en) * 1983-05-13 1985-01-16 LABORATORIO FARMACEUTICO LOFARMA s.r.l. Method for stably binding antigens and allergens to polystyrene and supports obtained
JPH04225163A (en) * 1990-04-13 1992-08-14 Abbott Lab Ige detecting method and apparatus and kit used in method thereof
JP2005077191A (en) * 2003-08-29 2005-03-24 Akita Prefecture Simple cryj1 immunoassay related to selection of low-allergen japanese cedar
US20050101031A1 (en) * 2000-10-03 2005-05-12 Reinhard Hiller Allergen-microarray assay
JP2008107154A (en) * 2006-10-24 2008-05-08 Green Peptide Co Ltd Method for diagnosing allergy to cedar pollen
WO2010110454A1 (en) * 2009-03-26 2010-09-30 国立大学法人名古屋大学 Method for diagnosis of allergic disease
JP2014512535A (en) * 2011-04-18 2014-05-22 マイクロテスト マトリシーズ リミテッド Immunoassay
JP2017527555A (en) * 2014-08-20 2017-09-21 エッペンドルフ アクチェンゲゼルシャフト Method for coating a solid support
JP2018171041A (en) * 2017-03-31 2018-11-08 Necソリューションイノベータ株式会社 Target analysis method and target analysis kit to be used for the same

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0131546A2 (en) * 1983-05-13 1985-01-16 LABORATORIO FARMACEUTICO LOFARMA s.r.l. Method for stably binding antigens and allergens to polystyrene and supports obtained
JPH04225163A (en) * 1990-04-13 1992-08-14 Abbott Lab Ige detecting method and apparatus and kit used in method thereof
US20050101031A1 (en) * 2000-10-03 2005-05-12 Reinhard Hiller Allergen-microarray assay
JP2005077191A (en) * 2003-08-29 2005-03-24 Akita Prefecture Simple cryj1 immunoassay related to selection of low-allergen japanese cedar
JP2008107154A (en) * 2006-10-24 2008-05-08 Green Peptide Co Ltd Method for diagnosing allergy to cedar pollen
WO2010110454A1 (en) * 2009-03-26 2010-09-30 国立大学法人名古屋大学 Method for diagnosis of allergic disease
JP2014512535A (en) * 2011-04-18 2014-05-22 マイクロテスト マトリシーズ リミテッド Immunoassay
JP2017527555A (en) * 2014-08-20 2017-09-21 エッペンドルフ アクチェンゲゼルシャフト Method for coating a solid support
JP2018171041A (en) * 2017-03-31 2018-11-08 Necソリューションイノベータ株式会社 Target analysis method and target analysis kit to be used for the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SASAKI, AKIRA, HOTTA, YASUO: "Development of techniques for determining amount of Japanese cedar pollen allergen (Cry jl)", TRANSACTIONS OF THE JAPANESE FORESTRY SOCIETY 2000, April 2002 (2002-04-01), pages 329 *
SATO KUMIKO ET AL: "Studies on Japanese Cedar Pollenosis II, Rapid determination of cedar pollen-specific IgE antibody by enzyme antibodytechnique using a microplate", THE ANNUAL REPORTS OF COLLEGE OF MEDICAL CARE AND TECHNOLOGY, vol. 6, 30 March 1986 (1986-03-30), pages 103 - 1047 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022158509A1 (en) * 2021-01-21 2022-07-28 東レ株式会社 Allergen-immobilized carrier and method for detecting allergen-specific antibody
WO2022211084A1 (en) * 2021-04-01 2022-10-06 富士レビオ株式会社 Method for treating biological sample

Also Published As

Publication number Publication date
JPWO2021015123A1 (en) 2021-01-28

Similar Documents

Publication Publication Date Title
Tempelman et al. Quantitating staphylococcal enterotoxin B in diverse media using a portable fiber-optic biosensor
EP2400301B1 (en) Allergen detection method using immunochromatography
EP3436823B1 (en) Antigen array
Jakob et al. Molecular allergy diagnostics using multiplex assays: methodological and practical considerations for use in research and clinical routine: Part 21 of the Series Molecular Allergology
CZ20031219A3 (en) detection method of immunoglobulins based on allergen chip
JP5342997B2 (en) How to determine allergic diseases
US4331650A (en) Identification of reagins in the blood serum of allergen sensitized vertebrates
WO2021015123A1 (en) Method for producing allergen-immobilized carrier, and method for detecting allergen-specific antibody
CN111549091B (en) Method for testing activation and degranulation of basophils
FI74818B (en) FOERFARANDE FOER DETEKTERING ELLER BESTAEMNING AV HISTAMIN I HISTAMINHALTIGA KROPPSVAETSKOR OCH ANALYTISK ANORDNING FOER DYLIKT FOERFARANDE.
WO2020102429A1 (en) Microfluidic device and diagnostic methods for allergy testing based on detection of basophil activation
US20050074410A1 (en) Methods for diagnosis of allergic bronchopulmonary aspergillosis
JP5633721B2 (en) Methods of providing data for predicting infant allergy development
JP4313778B2 (en) Detection reagent and detection method for heat-treated animal tissue-derived material
CN101358981A (en) Immune colloidal gold chromatography method for detecting food allergy to aquatic products
JP7510620B2 (en) Method for producing allergen-immobilized carrier and method for detecting allergen-specific antibodies
KR100488131B1 (en) Protein chip for diagnosis allergy and detecting method for allergen and antibody
US4486540A (en) Identification of reagins in the blood serum of allergen sensitized vertebrates
CN108982868A (en) The application of nucleome Protein S P110 and kit containing the albumen in preparation alcoholic myocardiopathy early diagnosis reagent
JP3547729B2 (en) Assay
JP2021148610A (en) Method for detecting allergen specific ige antibody in body fluid sample
CN107202882B (en) Purposes of the Rv0440 albumen in diagnosis latency/active tuberculosis
WO2022158509A1 (en) Allergen-immobilized carrier and method for detecting allergen-specific antibody
JP2003166994A (en) METHOD OF ANALYZING SAMPLE FOR ALLERGEN-SPECIFIC IgE
CN109813892A (en) Anarexol rapid time resolved fluorometric immunochromatographiassay assay quantitative detection test paper

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2020569213

Country of ref document: JP

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20844332

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20844332

Country of ref document: EP

Kind code of ref document: A1